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ABSTRACT  
SutA is upregulated during growth arrest in Pseudomonas aeruginosa and binds RNA polymerase 
(RNAP), causing widespread changes in gene expression. Using biochemical, structural and genetic 
methods, we examined how SutA interacts with RNAP and the functional consequences of these 
interactions.  SutA consists of a central α-helix with unstructured N and C-terminal tails. It binds to the 
β1 domain of RNAP and competes with DNA, leading to effects that are either activating or repressing, 
depending on the sigma () factor and promoter. Our data suggest that SutA is unlike conventional 
DNA-binding transcription factors, in that interactions between its α-helix and RNAP allow its acidic N-20 
terminal tail to modulate the path of DNA within the transcription initiation complex, while its C-
terminal tail stabilizes its interaction with RNAP. These activities help enhance expression of diverse 
genes, including essential ones such as the ribosomal RNA operons, under conditions of long-term 
resource limitation. 
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INTRODUCTION 
Despite the fact that most natural environments do not allow bacteria to double every 20-30 minutes, 
our understanding of essential cellular processes—such as DNA replication, transcription and 
translation—has been shaped by studies of a few model organisms growing exponentially at these rates, 
or responding to a rapid shift from exponential to slow growth. An open question of general importance 
is how the molecular machines responsible for transcription and translation, tightly coupled processes 30 
that are necessary to maintain homeostasis even when cell division is not occurring, adapt to long 
periods of low and uneven substrate availability (Bergkessel et al., 2016). Perhaps the best-studied 
example of growth-rate responsive control of bacterial gene expression is that of the E. coli ribosomal 
RNA operon (rrn). Many studies have shown that  complex interactions involving the specific 
characteristics of the rrn promoter, the activities of global regulators, and the physical realities of a 
nutrient-limited cell contribute to strong repression of rrn expression during slow growth or dormancy 
(Dennis et al., 2004). The major rrn promoter (P1) forms an extremely unstable open complex (OC), 
which helps drive high-level transcription by lowering the barrier for escape of RNAP from the promoter 
but also sensitizes it to perturbations during nutrient downshifts (Paul et al., 2004b). This sensitivity is 
exacerbated by the signaling molecule (p)ppGpp and its co-regulator DksA, which bind to RNAP and 40 
further destabilize the OC during early stationary phase, triggering RNAP dissociation, which can re-
direct the available transcriptional resources toward stress responses (Ross et al., 2016). If nutrient 
levels stay low, NTP concentrations drop, further repressing expression from rrn P1, as its unstable OC 
also makes it highly sensitive to the concentration of the initiating nucleotides (iNTPs) (Murray et al., 
2003b). Other stationary-phase changes, such as an increase in the abundance of active holoenzyme 
associated with the stress sigma factor (ES) relative to that associated with the housekeeping sigma 
factor (E70) (Ishihama, 2000), differences in the expression patterns of nucleoid-associated proteins, 
and a decrease in the DNA supercoiling imposed by transcription and replication activity, are also 
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thought to negatively impact initiation from rrn P1 (Meyer and Grainger, 2013). A second rrn promoter 
that drives low levels of expression and is insensitive to regulatory inputs, termed P2, has been 50 
proposed as the mechanism by which some rRNA transcription can be maintained during stationary 
phase (Murray et al., 2003a; Murray and Gourse, 2004); this paradigm implies that ribosome biogenesis 
is not actively modulated during protracted nutrient limitation. 
However, regulatory mechanisms, even for highly conserved processes like ribosome biogenesis in 
bacteria, are diverse (Stallings et al., 2009), and mechanisms operating during prolonged growth arrest 
have not been studied in great detail in any organism. P. aeruginosa and many other members of the 
Pseudomonadales order are notable opportunists, capable of utilizing diverse substrates for rapid 
growth but also capable of persisting in dormancy for long periods of time in low-nutrient environments 
(Udikovic-Kolic et al., 2014), making them attractive model systems for such studies. Furthermore, a 
better understanding of slow-growing or dormant states in P. aeruginosa is of clinical importance, as 60 
these states are thought to contribute to the notorious antibiotic tolerance of this organism during 
chronic infections (Babin et al., 2017; Ciofu et al., 2015; Olivares et al., 2013). Accordingly, in previous 
work we undertook a proteomics-based screen to identify P. aeruginosa regulators that are 
preferentially expressed during hypoxia-induced growth arrest.  We previously identified an RNAP-
binding protein, SutA, with broad impacts on gene expression that affected the ability of P. aeruginosa 
to form biofilms and produce virulence factors. Notably, SutA appeared to increase expression of the 
rRNA and r-protein genes under slow-growth conditions, as well as many genes with roles in nutrient 
scavenging, alternative metabolic pathways, and housekeeping functions, while repressing genes 
involved in virulence, motility, and defense (Babin et al., 2016).  
These observations led us to seek a mechanistic understanding of how SutA globally affects transcription 70 
during slow growth. Here we report biochemical, structural, and genetic studies aimed at elucidating 
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how SutA binds to RNAP and perturbs its function. Though our work focuses on a specific transcription 
factor in P. aeruginosa, the topic it tackles and the questions it raises are broadly relevant to 
understanding how bacteria survive periods of slow growth or dormancy in diverse environments. 
RESULTS 
SutA consists of a conserved alpha helix flanked by flexible N- and C-terminal tails 
SutA is a small (105 amino acids) protein with no similarity to any known domains. We began by looking 
at structure predictions (using the Jpred4 algorithm for secondary structure and DISOPRED3 for intrinsic 
disorder) and sequence conservation (Buchan et al., 2013; Drozdetskiy et al., 2015; Jones and Cozzetto, 
2015). SutA homologs are found in most organisms in the “Pseudomonadales-Oceanospirallales” clade 80 
of Gammaproteobacteria (Williams et al., 2010). Residues 56-76 are predicted to form an α-helix, 
followed by a 4-residue β-strand comprising residues 81-84, but the rest of the protein has no predicted 
secondary structural elements and residues 1-50 and 101-105 are predicted to be intrinsically 
disordered (Figure 1A). While the central, potentially structured region is reasonably well conserved, 
some homologs completely lack the last 15-18 residues, while others lack most or all of the first 40 
residues (Figure 1 – figure supplement 1). This suggests that the N-and C-terminal tails (N-tail and C-tail) 
might function independently and could be removed without affecting folding/function of other SutA 
regions.  
For structural characterization by NMR, we purified 15N and 13C labeled full-length SutA, as well as a 15N 
and 13C labeled construct that lacked most of the predicted disordered residues, SutA 46-101. We also 90 
constructed N-terminal (SutA ∆N, retaining residues 41-105) and C-terminal (SutA ∆C, retaining residues 
1-87) deletion mutants (Figure 1B). 
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 We were able to assign resonances and determine backbone chemical shifts for about 85% of the 
residues of the full-length protein (Table 1). Low sequence complexity and large regions of disorder 
caused a high degree of overlap in the spectra and made assignment difficult, but spectra from the 46-
101 variant were easier to assign, and served as a starting point for making assignments for the full-
length SutA. We focused on characterizing secondary structure chemical shift index values, R2 relaxation 
rates, and 1H-15N NOE magnitude and sign to gain insight into secondary structure elements and degree 
of disorder for each residue that we could assign. We also embedded the protein in a stretched 
polyacrylamide gel to achieve weak alignment, and calculated residual dipolar couplings (RDCs) by 100 
measuring differences in in-phase-antiphase spectra between the isotropic solution sample and the 
anisotropic stretched gel sample (Figure 1C). The results of these analyses lend credence to the 
bioinformatics predictions. Residues 56-76 show the positive Cα and CO and negative Hα secondary 
chemical shifts associated with α-helical structure (Wishart et al., 1991), and also show fast R2 relaxation 
rates and positive (1H-15N)NOE, signs that they are not disordered (Reddy and Rainey, 2010). Amide 
signals from disordered regions of the protein were almost completely absent from a 15N HSQC 
spectrum acquired with NOE, whereas amides in the helix gave positive peaks, and the residues very 
close to the N and C termini gave negative peaks. RDCs for the helix region are also positive, as has been 
observed for α-helical regions of a partially denatured protein (Mohana-Borges et al., 2004). While the 
short β-strand is less strongly supported, secondary shifts for those residues are mostly of the 110 
appropriate sign for a β-strand albeit of small magnitudes. In the N-tail, a small number of residues have 
a positive NOE signal or secondary shifts that are not near zero, but in general, the residues of this 
region have the low R2, secondary shift, and RDC values that are characteristic of disorder. The C-tail has 
several residues that show somewhat higher R2 values and non-zero RDCs suggestive of some degree of 
structure, but classic secondary structure elements are not apparent. To rule out the possibility that the 
disorder we observed might be a non-native state of SutA, we tested the protein we produced for the 
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NMR studies in our in vitro activity assays and found that its activity was the same as that of the 
unlabeled protein we produced by standard methods (Figure1 – figure supplement 2). We also collected 
15N HSQC spectra for 15N-labeled ∆N and ∆C mutants, and compared them to the full-length SutA (Figure 
1 – figure supplement 3). Consistent with phylogenetic analysis, the deletion of either tail had little 120 
impact on the remaining residues, affecting only the 2-4 residues adjacent to the newly created N- or C- 
terminus, justifying using these truncation mutants to assess the functions of the N- and C-tails.  
The difficulty of making unambiguous assignments for all residues and the high likelihood that much of 
the protein is intrinsically disordered precluded building a full NMR-based structural model of SutA. To 
model some of the conformations that might be adopted by SutA, we used the Robetta Server and 
PyRosetta to perform low-resolution Monte Carlo-based modeling, utilizing the chemical shifts and RDC 
values from our NMR analysis to guide fragment library construction (Bowers et al., 2000; Kim et al., 
2004; Rohl and Baker, 2002). A resulting model that conforms to the observations and predictions 
described above is shown in Figure 1D. On the left, sequence conservation across 25 representative 
homologs is shown; on the right, charged residues in the P. aeruginosa sequence.  The most highly 130 
conserved residues are found in the α-helix, and the C-tail is also highly conserved among homologs that 
have it. The N-tail is less conserved and varies in length, but is generally strikingly acidic. Additional 
models are shown in Figure 1 – figure supplement 4 (see materials and methods for modeling details). 
SutA affects transcription initiation in vitro 
We next wanted to investigate the direct effects of SutA on RNAP activity.  We first asked whether SutA 
affects transcription by the closely related E. coli RNAP enzyme. We found that overexpressing SutA in E. 
coli did not lead to rrn upregulation in vivo as it did in P. aeruginosa (Figure 2 – figure supplement 1) 
necessitating using the cognate P. aeruginosa in vitro transcription system. We purified the core RNAP 
(E) natively from a ∆sutA strain using a protocol originally designed for purifying E. coli RNAP and 
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previously used to purify RNAP from P. aeruginosa (Burgess and Jendrisak, 1975; Hager et al., 1990; 140 
Kuznedelov et al., 2011). The P. aeruginosa homologs of σS, σ70, and DksA, as well as SutA, were 
heterologously expressed in E. coli with cleavable N-terminal 6xHis tags and purified by metal affinity 
and size exclusion chromatography. We focused on initiation at three different P. aeruginosa promoters 
that we showed were upregulated by SutA in vivo (Babin et al., 2016) (Figure 2A). These promoters drive 
expression of a hypothetical bacteriocin (herein referred to as bcn, PA14_10380); a secreted amino 
peptidase (pepB, PA14_26020) and the ribosomal RNA operons (rrn).  For bcn and pepB, transcription 
start sites have been determined by two RNA-Seq studies that are in agreement (Schulz et al., 2015; 
Wurtzel et al., 2012). pepB has been experimentally confirmed to be part of the σS regulon, while bcn is 
transcribed efficiently by the σ70 holoenzyme (Eσ70), but not EσS (Figure 2). We mapped the dominant rrn 
transcription start site using 5’-RACE to a cytidine 8 bp downstream of the -10 consensus (Figure2 – 150 
figure supplement 2); while other possible transcription start sites are present within the 300 bp 
upstream of this site, it is unclear what role they may play in regulation of P. aeruginosa rrn 
transcription. We produced linear templates of 120-170 bp containing the rrn, pepB, and bcn promoters 
and 42-50 bp of transcript sequence for use in single-turnover initiation experiments (see materials and 
methods and supplements to Figure 2 for details).  
Because EσS binds the rrn locus in vivo during stationary phase in E. coli (Raffaelle et al., 2005), we 
sought to determine whether the SutA-dependent effects on rrn transcription we observed previously in 
P. aeruginosa were mediated through EσS, Eσ70 or both. In vitro, we found that addition of WT SutA 
caused increased amounts of rrn transcript in both holoenzyme contexts (Figure 2B), but the magnitude 
of the effect was much larger for EσS (up to 4-fold increase) than for Eσ70 (up to 70% increase) (Figure 160 
2C, top panels). In both cases, the effect was largest for concentrations of SutA between 125 and 500 
nM, and transcript levels decreased again at higher concentrations.  The acidic N-tail appears to be 
strictly required for activation, as the ∆N mutant inhibited transcription in a dose-dependent manner. 
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The ∆C mutant was still able to enhance transcription, albeit with a small shift in the concentration 
dependence, especially evident with EσS. These results suggest that the conserved central region 
containing the α-helix mediates SutA binding to RNAP and that the C-tail may also make a small 
contribution to this binding.  
We also tested EσS initiation from the pepB promoter and Eσ70 initiation from the bcn promoter (Figure 
2C, bottom panels). For pepB, the results were broadly similar to those obtained with EσS on the rrn 
promoter, although here the C-tail appears just as important as the N-tail. For bcn, the effect of SutA 170 
was opposite to that for rrn and, surprisingly, to what we had observed in vivo (Babin et al., 2016). The 
WT and ∆C proteins inhibited initiation to similar extents in a dose-dependent manner, while the ∆N 
SutA caused up to a 2-fold increase, with the greatest effect at the highest concentration tested.  
To test the relevance of these findings to slow-growth conditions in vivo, we generated constructs in 
which WT, ∆N, or ∆C SutA were under the control of an arabinose-inducible promoter, and integrated 
them into the chromosome of a ∆sutA strain of P. aeruginosa. We performed qRT-PCR on the three 
genes of interest, using cells harvested in stationary phase after growth in minimal media containing 
pyruvate as a carbon source (Figure 2D). To test the importance of σS, we also integrated the WT sutA 
construct into a ∆sutA ∆rpoS strain (∆S). For the rrn transcript, our in vivo qRT-PCR results largely 
mirrored the in vitro results:  WT SutA induction led to an increase in transcript, the ∆N protein failed to 180 
cause any increase, and the ∆C protein was only mildly defective. In the ∆rpoS strain, rrn levels were 
much lower in the absence of SutA, but achieved similar levels to the rpoS+ strain background upon SutA 
induction. This implies that SutA can meaningfully enhance σ70-driven production of rrn in vivo even 
though the magnitude of the in vitro effect on this holoenzyme is small, and further suggests that in 
vivo, under slow-growth conditions, σ70-driven rrn expression may be even more dependent upon SutA 
than σS-driven rrn expression. For pepB, the in vivo results confirmed its dependence on σS and matched 
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the in vitro results, with the ∆C protein showing a stronger defect than the ∆N protein. For bcn, the SutA 
effect was opposite to that observed in vitro, as expected based on our published data (Babin et al., 
2016), but one aspect was consistent with the in vitro results: the N-tail was required for the observed 
effect, while deletion of the C-tail had little effect. Many cellular factors (absent in our in vitro system) 190 
could contribute to the difference in behavior of the bcn promoter in the two contexts.  
SutA binds to the β1 domain of RNAP 
The above results demonstrate that SutA has direct effects on initiation. To map the region of RNAP with 
which SutA interacts, we used cross-linking and protein footprinting. The first cross-linking method used 
the homobifunctional reagent bis(sulfosuccinimidyl)suberate (BS3), which cross-links primary amines 
within about 25 Å of each other (Rappsilber, 2011). BS3 was added directly to complexes formed with 
purified core RNAP and SutA (Figure 3 – figure supplement 1), cross-linked complexes were digested 
with the peptidase Glu-C, and the resulting fragments were subjected to LC-MS/MS. Analysis performed 
with the software package Protein Prospector (Trnka et al., 2014) identified species that comprised one 
peptide from SutA and one peptide from RNAP (see materials and methods and Figure 3 – figure 200 
supplements 1 and 3 for additional details), thus allowing for mapping of cross-link sites. The second 
cross-linking method used the photoreactive non-canonical amino acid p-benzoyl-L-phenylalanine (BPA) 
that, when activated by irradiation with UV light, can form covalent bonds with a variety of moieties 
within 10 Å (Chin et al., 2002; Kauer et al., 1986).  We introduced BPA at 9 different positions of SutA (6, 
11, 22, 54, 61, 74, 84, 89, or 100), formed complexes with purified E and each of the BPA-modified SutA 
proteins, irradiated them with UV light, and visualized cross-linked species following SDS-PAGE (Figure 3 
– figure supplement 2). For the most efficient cross-linkers (BPA at positions 54 and 84), we determined 
the sites of the cross-links on RNAP by identifying cross-linked peptides via StavroX (Götze et al., 2012) 
analysis of LC-MS/MS data after tryptic digest of the complexes (Figure 3 – figure supplement 4).   
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Both cross-linking approaches identified interactions between the central region of SutA and the β1 210 
domain or nearby regions of the β subunit of RNAP (Figure 3A and B, green and orange). All SutA 
residues participating in the cross-links were within (BS3) or just outside (BPA) the α-helical region. BPA 
cross-linking is sensitive to the orientations of the interacting residues, so BPA positions within the helix 
that did not cross-link may not have been oriented optimally for the cross-linking reaction to occur.  
To identify the positions of the N- and C-tails, we designed variants of SutA for affinity cleavage 
experiments. We introduced cysteine residues at SutA position 2, 32, or 98 and conjugated the chelated 
iron reagent, iron-(S)-1-[p-(bromoacetamido)benzyl]EDTA (FeBABE), to these cysteines. FeBABE 
catalyzes localized (estimated to occur within 12 Å of the FeBABE moiety) hydroxyl radical cleavage 
reactions following exposure to ascorbate and peroxide (Meares et al., 2003). We assembled complexes 
with the FeBABE-modified SutA variants and RNAP, initiated the cleavage reactions, and analyzed the 220 
cleavage products by SDS-PAGE followed by Western blotting with an antibody against the C-terminus of 
β. To map the FeBABE cleavage positions, cleavage products were compared to β fragments of known 
sizes (Figure 3 – figure supplement 5). While the strongest cleavage product of the N-terminal FeBABE 
(at residue 2; N-Fe) was in the cleft between the β1 domain and the adjacent β2 domain (also called the 
β lobe), the strongest cleavage products of the C-terminal FeBABE (at residue 98; C-Fe) were in the long 
α-helix on the inside surface of β1, amongst the BS3 and BPA cross-linking sites (Figure 3A). The FeBABE 
at residue 32 was able to cleave at both β positions, suggesting that the N-tail is mobile to some degree 
even in the context of binding to RNAP. 
While most of the cross-links and cleavages mapped to β1 or the adjacent cleft, a cross-link was also 
detected between the 84 BPA position and β967, a residue located in βi9, an insertion in the β flap 230 
domain (Opalka et al., 2010). Additionally, weaker cleavage products for the N-Fe and C-Fe variants were 
detected at β721 and β1058 respectively, which are situated on either side of the βi9 (Figure 3B). We 
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consider this to represent a second, weaker site, because β967 is too far from the β residues 484 and 
493 that formed BPA cross-links for all of them to be reached from a single, stably bound position of the 
SutA 84. However, we note that we did not detect more than one shifted band after cross-linking with 
the 54 or 84 BPA variants (Figure 3 – figure supplement 2), suggesting that two separate sites on β are 
not likely to be occupied by two SutA molecules at the same time. Instead, it may be that SutA binding 
to a surface on the outside of the β1 domain, combined with rotation or translation of SutA along that 
surface and in conjunction with its flexibility, could allow for all of the observed cross-links and 
cleavages.  240 
To corroborate SutA-β interaction without cross-linking or cleavage and to interrogate which residues of 
SutA might directly participate therein, we conducted an NMR experiment. We were able to purify only 
a small amount of soluble β1 domain (colored darker blue in Figure 3C), which we mixed with an 
equimolar amount of 15N-labeled full-length SutA. As a control to rule out non-specific interactions, we 
mixed SutA with an equimolar amount of σS, which does not appear to bind SutA. Several SutA residues 
showed chemical shift perturbations in the β1 mixture, compared to the σS mixture (Figure 3D).  
Interestingly, three of these residues, K95, D97 and K99, would be on the same side of an extended 
peptide chain, supporting the interpretation that the C-tail contributes to SutA binding. The other 
perturbed residues flank the α-helix, suggesting that the regions at the junctions with the flexible tails 
may change conformation upon binding to β. 250 
SutA competes with both 70 and DNA for binding to RNAP 
Having established the site of SutA interaction with core RNAP, we next examined how the presence of 
promoter DNA or  factor might impact SutA binding to β1, and focused on the rrn promoter. In the E. 
coli rrn P1 promoter complex, the melted non-template DNA strand is located near β1, and interactions 
among the DNA,  and β regulate transcription initiation (Feklistov and Darst, 2011; Haugen et al., 2006; 
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NandyMazumdar et al.; Winkelman et al., 2015). SutA does not bind to dsDNA on its own, but we 
considered a possibility that it could change the dynamics of these interactions in the context of RNAP 
by bringing its flexible acidic N-tail in close proximity to the path of the DNA. We also hypothesized that 
this binding site could explain the difference in the magnitude of SutA’s impact on rrn initiation by E70 
compared to ES. Both  factors are highly conserved from P. aeruginosa to E. coli, and in both 260 
organisms, domains 2, 3, and 4 are highly similar between the two  factors. In addition, both 70 and S 
have unstructured acidic regions near their N-termini (Gowrishankar et al., 2003). However, 70 contains 
a large (~245 amino acids) insertion, termed the “non-conserved region” or NCR, which is not present in 
S (Figure 4A). Crystal and cryoEM structures show that most of the NCR is situated fairly far from β1, 
contacting the β’ subunit on the opposite side of the main channel of RNAP, but an unusually acidic 
stretch of ~40 residues within the NCR is too flexible to be resolved in these structures (Basu et al., 
2014; Narayanan et al., 2018; Zuo and Steitz, 2015). To investigate possible interactions between this 
flexible acidic loop (AL) and SutA, we threaded the P. aeruginosa sequence onto the β subunit of an E. 
coli RNAP crystal structure (Molodtsov et al., 2017) docked that model into the recent cryoEM structure 
of the E. coli E70 OC (Narayanan et al., 2018) and modelled the missing 70 AL (using the E. coli 270 
sequence for both the structured and flexible regions of 70) using the MODELLER software suite (Yang 
et al., 2012). The highly flexible AL could occupy a wide range of positions (e.g., Figure 4A, top), some of 
which would stay well above the position of the DNA in the main channel (position 1) and some of which 
clash with the DNA as they reach into and across the main channel toward β1 (position 2). This modeling 
shows that 70 AL is long enough and its structurally resolved ends are positioned appropriately to allow 
it to reach the β1 residues that participate in SutA cross-links and cleavages, especially in the absence of 
DNA. To determine whether the AL might contribute to the observed differences between E70 and ES 
activation by SutA, we constructed and purified a P. aeruginosa 70 mutant lacking residues 171-214 
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(∆AL), which correspond to the region missing in the E. coli structure, and repeated our cross-linking and 
cleavage assays with or without DNA using E70, ES or E70∆AL holoenzymes instead of E. 280 
To maximize the sensitivity of our cross-linking assay, we used the SutA L54BPA variant, which gave the 
most efficient cross-link with the core enzyme alone, and performed Western blots using the β antibody. 
In the absence of DNA, E70 produced noticeably less cross-linking than E or ES. Interestingly, E70∆AL 
largely restored the cross-linking to the levels seen with E or ES (Figure 4C, lanes 1-4). This difference in 
SutA cross-linking between E70 and E70∆AL decreased at higher SutA concentrations, as might be 
expected if SutA and AL are competing to occupy a similar space. 
To test the effect of DNA on the SutA-β interaction, we used either a double-stranded (ds) rrn promoter 
DNA or a bubble template in which the region of the DNA that forms the transcription bubble in the OC 
was non-complementary (Figure 4B). The dsDNA requires σ to melt the DNA strands and will support the 
formation of a native population of DNA-RNAP complexes. By contrast, the bubble template obviates 290 
the need for σ and would be expected to stabilize an OC formed with the holoenzyme, but this complex 
may not represent the dominant native complex; the E. coli rrn P1, for example, does not form a stable 
OC (Ruff et al., 2015a). The addition of the bubble DNA had a large negative effect on SutA binding that 
was synergistic with the presence of σ (Figure 4C, lanes 5-8). Cross-linking could still be readily detected 
in the absence of σ, and to a lesser extent when S was present, but not with either 70 or 70∆AL; 
longer exposures revealed that cross-linking did occur at low efficiency (Figure 4 – figure supplement 1).  
Addition of dsDNA allowed more SutA binding than the bubble template, but still less than was seen in 
the absence of DNA (Figure 4C, lanes 9-11), suggesting that the artificial bubble OC lacks the native 
intermediate to which SutA preferentially binds.  
To test the effects of DNA and σ on β interactions with the SutA tails, we used FeBABE cleavage assays 300 
with the N-Fe and C-Fe SutA variants (Figure 4D). While the results were consistent with those obtained 
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by BPA cross-linking, we also observed that the cleavage induced by C-Fe SutA was increased in the ∆AL 
mutant, whereas the N-Fe cleavages were either unaffected or inhibited. This result suggests that AL 
may clash specifically with the C-tail of SutA.  
We failed to detect either cross-linking to or cleavage of the E. coli E70 (Figure 4 – figure supplements 1 
and 2). This is consistent with our observation that overexpression of SutA in E. coli fails to upregulate 
rrn expression and suggests that the interaction between SutA and the P. aeruginosa RNAP is species-
specific.        
SutA enhances RNAP-DNA interaction on the rrn promoter, and its tails access the transcription 
bubble DNA 310 
Given that promoter DNA reduces SutA cross-linking to RNAP, we might predict the corollary: SutA 
would reduce the RNAP-DNA interaction through its competition with promoter DNA. But this would be 
counterintuitive for a factor that enhances transcription. To investigate how SutA affects the RNAP-DNA 
interaction, we measured permanganate reactivity of the template strand of the rrn promoter, in the 
presence of different holoenzymes and SutA variants.  Permanganate can oxidize thymines (and to a 
lesser extent, cytidines and guanines) only when the DNA bases are unstacked, as occurs when it is 
single-stranded, so reactivity can be used to detect promoter melting by RNAP (Kahle and Paule, 2009). 
We detected intense bands corresponding to oxidation of bases -12 to -9 upstream of the transcription 
start site, indicative of the population of OCs in which the σ factor has mediated strand opening (Figure 
5A), but because the P. aeruginosa rrn promoter template strand lacks any thymines downstream of -9, 320 
we cannot distinguish between early and late OC intermediates (see Discussion).  We carried out the 
footprinting experiments in triplicate and quantified the signal from the -12 to -9 footprint to serve as a 
measure of the steady state amount of strand-separated OCs (Figure 5B); Figure 5A shows one 
representative set of measurements. The addition of WT SutA did not have a significant negative effect 
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on the interaction between RNAP and the rrn promoter DNA in any of the holoenzyme contexts. For ES, 
the addition of either 250 nM or 2 µM SutA actually increased the RNAP-DNA interaction (although the 
effect is only statistically significant at 2 µM SutA), suggesting that in this context, SutA may even 
stabilize at least one OC intermediate in which the DNA strands are melted. For E70, the footprints are 
stronger overall but the effect of SutA is very subtle, and peaks at 250 nM SutA. Also, for both 
holoenzymes, deletion of the C-tail of SutA has a negative effect on the RNAP-DNA interaction, possibly 330 
suggesting that it can contribute to stability of some RNAP-DNA-SutA complexes as well as RNAP-SutA 
interactions, consistent with its effects on SutA in vitro transcription activity (Figure 2). Although the ∆AL 
had a substantial effect on the RNAP-SutA interaction, it appears to have only very mild effects on the 
RNAP-DNA interaction, consistent with mild effects on transcription activity (Figure 4 – figure 
supplement 3). 
Based on the positions of the SutA cross-links and evidence that it can enhance RNAP-DNA interactions 
in some contexts, we expected that we should be able to detect evidence of SutA-DNA proximity in a 
ternary complex containing holoenzyme, SutA, and DNA. To test this, we measured FeBABE SutA-
dependent cleavage of the template and non-template DNA strands using primer extension. We saw 
stronger cleavage with ES than with E70, but in both cases the cleavage was fairly weak, as might be 340 
expected for a factor that does not directly bind DNA (Figure 5C). In the ES complex, the C-Fe induced 
cleavage of both strands between residues -8 and -12, suggesting that it remains near the upstream fork 
junction of the transcription bubble.  The N-Fe cleaves the template strand near the upstream junction 
but also cleaves both strands further downstream. For E70, the cleavage was weaker overall and 
showed a different pattern; for C-Fe in particular, more cleavage took place on the downstream region 
of the non-template strand. This difference could reflect the fact that 70 AL seems to compete with the 
C-terminus of SutA, potentially causing it to favor a slightly different position in the ternary complex. 
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SutA does not directly stabilize the rrn OC formed by E70 holoenzyme 
In E. coli, control of rRNA synthesis is dictated by an inherent instability of the rrn P1 OC. DksA/ppGpp 
further destabilize the complex, inhibiting transcription, whereas the initiating nucleotide (iNTP) exerts 350 
an opposite effect (Paul et al., 2004a). Accordingly, we wanted to determine 1) whether the P. 
aeruginosa rrn OC is also unstable and sensitive to these inputs, and 2) whether SutA affects the OC 
stability. First, we purified the P. aeruginosa DksA, and measured transcription from the rrn promoter by 
E70, in the presence or absence of SutA and also DksA plus ppGpp (Figure 6A, Figure 6 – figure 
supplement 1). As observed in E. coli, DksA and ppGpp strongly repressed rrn transcription. When SutA 
and DksA/ppGpp were added together, it appeared that SutA might still have a small positive effect 
(though this effect is not statistically significant), but it certainly did not reverse the strong repression by 
DksA/ppGpp, suggesting that SutA functions in a different way. Next, we measured rrn transcription at 
different [iNTPs] (Figure 6B, Figure 6 – figure supplement 2). Also consistent with observations in E. coli, 
transcription was strongly repressed at low [iNTPs], but SutA had no effect at the lowest concentration, 360 
and similar small effects at two higher concentrations. Finally, we directly measured the half-life of the 
(heparin-resistant) E70 OC in a transcription-based assay. In contrast to what has been seen in E. coli, 
we detected some OC at standard salt concentrations and on a linear template, but its half-life was quite 
short, at about 45 seconds. Addition of SutA at 125 or 500 nM had no significant effect (Figure 6C, Figure 
6 – figure supplement 3). Taken together, these results suggest that while the P. aeruginosa rrn 
promoter forms an inherently unstable OC, which is sensitive to regulatory inputs that utilize its 
instability, SutA does not appear to function by directly countering the OC dissociation. 
To explore further the relationship between the OC and SutA activity, we used a premelted bubble 
template (Figure 4B, Figure 6D, Figure 6 – figure supplement 4). Any effects that SutA has on the 
formation (or stability) of the OC should no longer impact transcription from this template, since the OC 370 
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cannot collapse. SutA still had a small effect on initiation by E70 in the context of the bubble template 
(Figure 6D, black symbols), but less than was observed with the dsDNA template (Figure 6D, black lines), 
suggesting that it may act both by contributing to formation of the OC (the fraction of the activity that is 
lost in the bubble template) and by having an additional effect independent of OC formation. We also 
measured initiation on the bubble template by ES. Interestingly, transcription was much more robust 
than was seen with the dsDNA template (Figure 6D, compare red symbols to red lines), and the effects 
of SutA were much smaller. We were unable to reliably measure the effects of SutA on ES OC stability 
due to low signal, especially in the absence of SutA, but these results suggest that facilitating OC 
formation and/or stabilization are the major function for SutA in this context. The residual impact of 
SutA on the bubble template is similar to that seen for E70.   380 
SutA destabilizes RNAP-DNA interactions on the bcn promoter 
In contrast to its activation of the pepB and rrn promoters, SutA directly represses the bcn promoter in 
vitro (Figure 2). Even though this effect is different than that observed in vivo, we were interested in 
exploring the mechanistic differences between the bcn and rrn promoters. We found that bcn OC was 
very stable, with a measured half-life of about 60 minutes (Figure 7A, Figure 7 – figure supplement 1) 
that was unaffected by SutA. bcn behavior in the other assays was very different from the rrn promoter 
— the cross-linking, cleavage, and footprinting results suggest that SutA and the bcn promoter DNA are 
mutually destabilizing for interactions with RNAP. First, SutA seems to interact much less efficiently with 
E70 in the presence of the bcn compared to the rrn promoter (Figure 7B; data for rrn promoter is the 
same as in Figure 4C/D and is shown again for direct comparison). Nevertheless, SutA disrupts the 390 
interaction between the promoter DNA and RNAP as reported by permanganate footprinting; this effect 
is mediated by the N-tail and is particularly strong for the ∆AL holoenzyme (Figure 7C, D, and Figure 7 – 
figure supplement 2). We were unable to detect any significant cleavage of the bcn DNA by the SutA 
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FeBABE variants, as would be expected if the ternary complex were rare or unstable (Figure 7 – figure 
supplement 3). Taken together, these results suggest that, in contrast to its activity on the rrn promoter, 
SutA inhibits OC formation on the bcn promoter, and that this activity is dependent on its N-tail.  
DISCUSSION 
The advent of inexpensive, high-throughput sequencing has opened a new window into the 
transcriptional activities of bacteria, many representing previously unknown species, living in a plethora 
of environments. This information explosion invites reconsideration of how our basic models for 400 
mechanisms of transcriptional regulation relate to the conditions experienced by diverse bacteria in 
nature. In particular, mechanisms for modulating transcriptional dynamics during prolonged starvation 
for nutrients, a pervasive condition in many environments, have not been extensively studied. We 
viewed SutA as a vehicle through which to gain insight into such dynamics in P. aeruginosa. Our previous 
work showed that SutA is upregulated specifically under conditions of slow growth or growth arrest, 
that it binds directly to RNAP, and that it modulates expression of hundreds of genes, including the 
highly regulated rrn operon. Our goal in this study was to investigate how SutA might affect RNAP 
function, by determining its structural characteristics and binding site on RNAP, and by measuring its 
direct effects on transcription initiation in vitro on rrn and two other promoters that appeared strongly 
affected in vivo. 410 
SutA has no homology to any previously described domain but its sequence predicts large regions of 
intrinsic disorder surrounding a short central α-helix, as we confirmed by NMR. Importantly, its 
completely disordered N-tail is critical for its function, while the C-tail, which displayed some signs of 
order but no classical secondary structure elements, contributes to binding RNAP.  Although the 
extreme flexibility of SutA and the relatively large distances over which our cross-linking and cleavage 
reagents could act (10-25 Å) preclude precise docking of SutA onto RNAP, a binding site on the outside 
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of the β1 domain is consistent with our data. Most of the β1 residues are identical (72%) or similar (87%) 
between E. coli and P. aeruginosa, but two less-conserved loops contain residues involved in BS3 cross-
linking (K45 and K116) and could contribute to the observed species specificity. From such a binding site 
for the SutA helix, its flexible tails can still reach around either side of the β1 domain into the region 420 
occupied by the open transcription bubble. Although the binding site of SutA is distinct from binding 
sites of previously characterized regulators, recent structures of other highly flexible transcription 
modulators that bind elsewhere have shown that unstructured elements can reach deep into RNAP to 
alter its function (Kang et al., 2017).  
Transcriptional regulators that do not bind DNA directly must exert their effects by altering the 
conformation of RNAP and /or DNA and can thus regulate many different promoters either positively or 
negatively, depending on the promoter properties. Our findings that SutA modulates expression of 
numerous genes (Babin et al., 2016) and has distinct promoter-dependent effects (this work) conform to 
general expectations of regulators that do not bind DNA. Our results also suggest that SutA interactions 
with RNAP are modulated by a long flexible acidic loop present in σ70 but not σS, explaining in part the σ-430 
specific effects of SutA. Although the σ70AL has not been previously implicated in transcription 
regulation, other mobile elements of the β, β’ and σ RNAP subunits have been shown to contribute to 
OC formation and stability (Hook-Barnard and Hinton, 2009; NandyMazumdar et al.; Ruff et al., 2015a) 
and to be targeted by regulators that can interrupt the initiation pathway by locking these flexible 
modules in place (Bae et al., 2013).  
A detailed understanding of the manner by which SutA alters the conformations of specific RNAP -
promoter complexes, and how these alterations lead to the observed effects on initiation, awaits future 
studies, but viewing our results in the context of the paradigm established by extensive studies in E. coli 
provides a model for consideration. During initiation, RNAP binds to the promoter DNA through contacts 
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primarily established by  to form a closed complex, setting in motion a series of steps in which RNAP 440 
bends and opens the DNA duplex to form an initial unstable OC in which  holds the non-template 
strand. The initial OC then isomerizes (through a series of intermediates that are likely different for 
different promoters) into a final OC, in which the bubble encompasses -12 to +1, the downstream DNA is 
held tightly, and the iNTP can load into the active site (Ruff et al., 2015b). The stability of the final OC 
varies tremendously among different promoters (Ruff et al., 2015b). Decades of studies of rRNA 
synthesis in E. coli have identified the unique properties of the rrn P1 promoter that make it one of the 
strongest promoters, but also very sensitive to regulation. A combination of suboptimal spacing (16 bp) 
between the near consensus -35 and -10 hexamers, a GC-rich 8-nt (as compared to the optimal 6-nt) 
discriminator region that separates the -10 hexamer and the +1 position, and a C residue 2 nt 
downstream of the -10 hexamer that cannot make productive contacts to σ70 lead to very short-lived 450 
OCs in which the non-template DNA is scrunched by 2 nts and extruded into solution between β1 and β2 
domains (Haugen et al., 2006; Winkelman et al., 2016; Winkelman et al., 2015). Importantly, the rrn P1 
OC does not appear to undergo the final isomerization steps to reach the stable final OC (Ruff et al., 
2015b).  
While detailed information is not available for P. aeruginosa rrn promoter complexes, they have all the 
canonical rrn P1 features except that the discriminator is 7 instead of 8 nt. Consistently, our data show 
DksA /ppGpp repression, iNTP sensitivity, and an OC half-life that is quite short (45 s), although not as 
short as that for E. coli rrn (~1 s), a difference that is likely due to the shorter discriminator (Henderson 
et al., 2017). We note that promoters with 7-nt discriminators also form 1-nt pre-scrunched and 
unstable OCs; interestingly, the region proposed to accommodate the scrunched non-template strand is 460 
the cleft adjacent to β1 where most of our SutA cross-links and cleavages occurred (Winkelman et al., 
2015). In contrast, promoters with 6-nt discriminators make favorable contacts to σ and are much more 
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stable (Henderson et al., 2017); bcn is such a promoter, with a 6-nt discriminator and long (~60 min) OC 
half-life.  
Unlike DksA, which exerts its effects by destabilizing OCs (Paul et al., 2004a), our data suggest that SutA 
does not alter the OC stability at either the rrn or bcn promoter, perhaps because SutA does not appear 
to efficiently bind stable Eσ70 OC, represented by the rrn bubble template and the naturally stable OC 
formed on the bcn promoter. SutA increases transcription from rrn, but represses transcription from bcn 
in vitro. As proposed for DksA (Rutherford et al., 2009), these opposing effects could be due to SutA 
acting to lower the free energy of an OC intermediate or change the activation barriers of different 470 
transition steps en route to the final OC on these two (and other) promoters. Interestingly, in vivo, the 
effects of SutA on the bcn promoter are positive and the strongest that we observed for any gene in the 
genome (Babin et al., 2016).  Several possibilities to explain this discrepancy could fit within the outlines 
of this model, but broadly, the participation of an additional cellular factor that changes the 
characteristics of the intermediate with which SutA interacts could have the effect of flipping its 
influence on transcription from negative to positive. Identifying such a factor is an interesting objective 
for future work.  
SutA effects on the global transcriptome could also be nuanced through its distinct interactions with 
holoenzymes formed with σ70 and σS, closely related σ factors with partially overlapping promoter 
specificities (Feklistov et al., 2014; Schulz et al., 2015). The C-tail of SutA may be a key contributor to 480 
these differences. Our NMR analysis suggests that residues in the C-tail directly participate in binding to 
β1, yet the interaction of the C-tail with RNAP is inhibited by the σ70 AL in the context of the 
holoenzyme. Consistent with these observations, the C-tail is more important for activation of rrn and 
pepB, and makes a bigger contribution to enhancing the RNAP-DNA interaction in the context of EσS. 
Taken together, these results suggest that SutA may play a more important stabilizing role for some OC 
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intermediate formed by EσS than it does in the context of Eσ70 (Figure 8). Interestingly, both σ factors 
seem to have a small residual positive effect on initiation even when the OC is pre-formed and 
stabilized, as is the case for the artificial bubble template. We do not know the nature of this effect, but 
our published ChIP-Seq data (Babin et al., 2016) suggest that SutA can associate with elongating RNAP, 
and are consistent with the notion that SutA could influence RNA synthesis at stages after the formation 490 
of the OC. 
In conclusion, this work has provided structural and functional insight into how SutA can impact RNAP in 
growth-arrested cells. Many intriguing questions remain: First, what are the promoter characteristics 
that SutA recognizes to favor transcription from some yet disfavor transcription from others and thus 
redistribute transcriptional resources in energy-limited cells? Second, how does SutA navigate changes 
in EσS vs. Eσ70 abundance over different phases of growth and growth arrest so as to efficiently optimize 
expression of a subset of genes? Third, what other factors interact with SutA during slow growth and 
dormancy? Fully understanding the regulatory architecture that gives rise to the impressive ability of P. 
aeruginosa to tolerate slow-growth and dormancy is a long-term challenge, yet an improved 
mechanistic understanding of SutA, a global regulator active in these states, represents an important 500 
step towards that end.     
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MATERIALS AND METHODS 520 
Media and Growth Conditions. All cultures were grown at 37 °C with shaking unless otherwise noted. 
Liquid media were LB (5 g yeast extract, 10 g tryptone, 10 g NaCl per liter), Terrific Broth (TB) (24 g of 
yeast extract, 20 g of tryptone, and 4 mL of glycerol per liter, buffered to pH 7.0 with 18.9 mM 
potassium phosphate ), or phosphate buffered minimal medium (35.9 mM K2HPO4, 14.2 mM KH2PO4, 9.3 
mM NH4Cl, 42.8 mM NaCl, 1.0 mM MgSO4, 7.5 µM FeCl2·4H2O, 0.8 µM CoCl2·6H2O, 0.5 µM MnCl2·4H2O, 
0.5 µM ZnCl2, 0.2 µM Na2MoO4·2H2O, 0.1 µM NiCl2·6H2O, 0.1 µM H3BO3, 0.01 µM CuCl2·2H2O) with 40 
mM sodium pyruvate added as a carbon source. 
Strain and plasmid construction. See Table 2 (strains and plasmids) and Table 3 (primers) for relevant 
details. In general, standard methods were used for plasmid and strain construction. The strains with 
constructs for arabinose-inducible overexpression of SutA or its N- or C-tail truncations were made by 530 
introducing the relevant  pUC18T-mini-Tn7T-GmR construct (DKN1639, DKN1876, or DKN1877) into P. 
aeruginosa UCBPP-PA14 ∆sutA (DKN1625) or ∆sutA∆rpoS (DKN1955) by tetraparental conjugation, as 
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previously described (Choi and Schweizer, 2006). DKN1876 and DKN1877 were generated using 
outward-facing primers followed by blunt ligation of the DKN1639 plasmid. To generate the ∆sutA∆rpoS 
strain, the sutA gene was cleanly deleted from the ∆rpoS strain (Basta et al., 2017) by conjugation with 
strain DKN1637 and then counterselection as previously described (Babin et al., 2016). For comparing 
the effects of SutA overexpression in E. coli to its effects in P. aeruginosa, either the expression plasmid 
(from strain DKN1640) or the empty vector (from strain DKN548 (Shanks et al., 2006)) was transformed 
by electroporation into either the P. aeruginosa ∆sutA strain (DKN1625) or E. coli MG1655 (DKN81). For 
overexpression and Ni-NTA purification of SutA, a plasmid in which the an HA-tagged sutA gene had 540 
been amplified and cloned into the multiple cloning site of pQE-80L (Qiagen) between the BamHI and 
HindIII restriction sites (DKN1643) was amplified using outward-directed primers flanking the sequence 
for the HA tag (not amplifying it) and encoding the TEV cleavage site. The PCR product was 
phosphorylated and subjected to a blunt end ligation to generate the plasmid encoding a 6His-TEV-SutA 
construct, and this was transformed into BL31 DE3 cells to generate strain DKN 1697. This construct was 
subjected to site directed mutagenesis using outward-facing primers encoding the desired changes to 
generate all of the SutA variant constructs used in this study (DKN1879-DKN1892), except SutA 46-101 
(DKN1878). Sequences of SutA46-101, DksA (DKN1893) and rpoB β1 (DKN1895) were cloned out of 
genomic DNA from P. aeruginosa UCBPP-PA14 and into the pQE-80L plasmid from strain DKN1697, 
replacing the SutA sequence but retaining the TEV cleavage site, using Gibson assembly (Gibson, 2011). 550 
The rpoD and rpoS sequences were cloned from P. aeruginosa gDNA and into the pET15b vector 
(DKN1901 and DKN1894, respectively), as expressing rpoDfrom pQE-80L proved somewhat toxic to E. 
coli. The 70∆171-214 construct (DKN1902) was generated using outward facing primers and blunt-end 
ligation of the plasmid from strain DKN1901. Fragments of βto use as standards in the affinity cleavage 
experiment were cloned from P. aeruginosa gDNA into pQE-80L, removing the sequence for the 6xHis 
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affinity tag and TEV cleavage site, by Gibson assembly (DKN1896-DKN1900). Template sequences were 
cloned from P. aeruginosa gDNA into the pUC18 vector (DKN1903-DKN1905).   
Protein purification.  
RNAP: RNAP was purified from the P. aeruginosa ΔsutA strain essentially as previously described 
((Kuznedelov et al., 2011) and references therein). Briefly, cells were grown in 6 L of TB to an OD600 of 560 
approximately 1.0. Cells were washed with TBS and pellets were frozen at -80 °C. Cell pellets were 
resuspended in 90 mL RNAP lysis buffer (50 mM Tris pH 8.0, 100 mM NaCl, 1 mM EDTA, and cOmplete 
complete Ultra EDTA-free protease inhibitor tablets (Roche)) containing 40 Kunitz units DNAseI and cells 
were lysed by passage through an EmulsiFlex-C3 (Avestin). Lysates were clarified by centrifugation at 
12,000 xg, and nucleic acids and acidic proteins were precipitated by addition of a 10% 
polyethyleneimine (polymin P; Sigma-Aldrich) solution at pH 7.9 to a final concentration of 0.5%. 
Precipitated protein was pelleted, washed with TGEB (10 mM Tris pH 8.0, 5% glycerol, 0.1 mM EDTA, 10 
mM β-mercaptoethanol) plus 0.3 M NaCl, and the RNAP fraction was eluted with TGEB plus 1 M NaCl. 
Residual polymin P was removed by ammonium sulfate precipitation (2M). The ammonium sulfate pellet 
was resuspended in TGEB and loaded onto a 50 mL Heparin Sepharose 6 Fast Flow column (GE 570 
Healthcare). The column was washed with 2 column volumes of TGEB plus 0.3 M NaCl, and RNAP was 
eluted with a step to TGEB plus 0.6 M NaCl. The elution fraction was precipitated with 2 M ammonium 
sulfate, and resuspended into approximately 1 mL of TGEB plus 0.5 M NaCl. Low molecular weight 
contaminants were removed via size exclusion chromatography on a HiPrep 16/60 Sephacryl S-300 HR 
column (GE Healthcare). Fractions containing RNAP were diluted in TGEB to a final NaCl concentration of 
0.3 M and loaded onto a HiTrap Q HP 5 mL column (GE Healthcare). RNAP was eluted into TGEB with a 
gradient between 0.3 M and 0.5 M NaCl over 20 column volumes. RNAP was dialyzed into RNAP storage 
buffer (20 mM Tris-HCl pH 8.0, 0.1 mM EDTA, 10 mM β-mercaptoethanol, 100 mM NaCl, 20% glycerol), 
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concentrated to 1.4 mg/mL and frozen at -80 °C. The total yield was approximately 2.9 mg of high purity 
core enzyme. 580 
6xHis-tagged proteins: For all tagged proteins, the following central steps were in common, and initial 
protein expression and lysis steps, plus additional purification steps specific to each protein are detailed 
below: Soluble protein was mixed with His-Pur Ni-NTA beads (Thermo Scientific or Clontech) in batch 
and binding was allowed to occur for 1h at 4 °C. Beads were washed three times with lysis buffer 
containing 20 mM imidazole and eluted three times with lysis buffer containing 250-500 mM imidazole. 
Eluents were combined, loaded onto an Amicon 3 or 10 kDa centrifugal filter (EMD Millipore), and buffer 
exchanged to TEV-digestion buffer (50 mM Tris pH 8.0, 0.5 mM EDTA, and 1 mM DTT). The 6xHis-tag was 
cleaved by addition of His-tagged TEV protease in a 1:50 mass ratio and incubation overnight at 4 °C. 
The digested sample was reapplied to His-Pur Ni-NTA, and washed with lysis buffer containing 20 mM 
imidazole; the protein of interest remained unbound or was eluted in this wash step, while the cleaved 590 
peptide tag and His-tagged TEV protease remained bound to the resin. The cleaved protein product 
includes the native protein sequence with an additional N-terminal serine (or glycine for 70purified 
from the pET15b vector).  
SutA (unlabeled): Strain DKN1697 was grown with 200 µg/ml ampicillin. A 20 mL culture grown 
overnight in LB was distributed between two flasks, each containing one liter of 2xYT and grown at 37 °C 
to OD600=0.6. Protein expression was induced by addition of 1 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG) and expression was allowed to continue for 4 hr. Cells were pelleted and 
frozen at -80 °C. Pellets were resuspended in lysis buffer (40 mM NaH2PO4, 300 mM NaCl, pH 8) 
containing 5 mM imidazole, 1 mg/mL lysozyme, and cOmplete mini protease inhibitor, EDTA free and 
lysed by probe sonication. The lysate was treated with Benzonase Nuclease on ice for 30 min and 600 
centrifuged. Following TEV cleavage of the SutA protein, the protein was concentrated on an Amicon 
.CC-BY-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/423384doi: bioRxiv preprint first posted online Sep. 20, 2018; 
27 
 
Ultra-15 centrifugal filter, applied to a Superdex 75 10/300 column, buffer exchanged to SutA storage 
buffer (25 mM Tris pH 8, 100 mM NaCl, 20% glycerol, and 2 mM β-mercaptoethanol), and stored at -80 
°C. 
SutA 46-101 (15N13C): Strain DKN1878 was grown overnight in 10 ml LB and then split between two 
baffled flasks containing M9 minimal salts medium (6 g/L sodium phosphate dibasic, 3 g/L potassium 
phosphate monobasic, 0.5 g/L NaCl, 1 g/L 15NH4Cl (Cambridge Isotope Laboratories, Cambridge MA), 2.5 
g/L 13C glucose(Cambridge Isotope Laboratories)) supplemented with 100 µg/ml carbenicillin (Gold Bio), 
1 mM MgSO4, 300 µM CaCl2 and trace metals (7.5 µM FeCl2·4H2O, 0.8 µM CoCl2·6H2O, 0.5 µM 
MnCl2·4H2O, 0.5 µM ZnCl2, 0.2 µM Na2MoO4·2H2O, 0.1 µM NiCl2·6H2O, 0.1 µM H3BO3, 0.01 µM 610 
CuCl2·2H2O). Cultures were grown at 37 °C until they reached mid-exponential phase (8 hrs) and then 
protein expression was induced by adding IPTG to a final concentration of 1 mM. Cells were harvested 
after 5 hr of induction and frozen at -80 °C. Pellets were resuspended in lysis buffer (50 mM sodium 
phosphate, pH 8.0, 300 mM NaCl, 5 mM imidazole) plus 20 Kunitz units DNaseI and EDTA-free cOmplete 
mini protease inhibitor tablets (Roche) and lysed by passage through an EmulsiFlex-C3. Following TEV 
cleavage, the protein was concentrated and loaded onto a Hi-Load 16/600 Superdex75 pg size exclusion 
column, buffer exchanging into the NMR buffer containing 20 mM sodium phosphate pH 7.0 and 100 
mM sodium chloride.  
SutA WT (15N13C): Strain DKN1697 was grown, protein expression induced, and cells lysed as described 
for the SutA 46-101 (15N13C) protein. As an additional purification step following TEV cleavage, the 620 
protein was concentrated and buffer exchanged into a buffer containing 20 mM N-methylpiperazine, pH 
5.0, and 100 mM NaCl and loaded onto a 5 ml HiTrap Q Sepharose fast flow anion exchange column (GE 
Healthcare Life Sciences). The protein was eluted with a 20 column-volume gradient to 600 mM NaCl 
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and then was concentrated to 1 ml before size exclusion chromatography as described for the SutA 46-
101 (15N13C) protein.    
SutA WT (15N): Protein was produced and purified as described for the SutA WT (15N13C) protein, except 
glucose with the natural carbon isotope ratios was used at 4 g/L.  
SutA∆N unlabeled: Strain DKN1879 was grown overnight in 5 ml LB then diluted 1:200 into TB plus 100 
µg/ml carbenicillin and grown at 37 °C. Expression was induced when the culture reached mid-
exponential phase with 1 mM IPTG and cells were harvested after 4 hrs of induction. Lysis and 630 
purification steps were the same as described for the SutA 46-101 (15N13C) protein, and the final protein 
storage buffer was 25 mM Tris pH 8, 100 mM NaCl, 20% glycerol, and 2 mM β-mercaptoethanol.  
SutA∆C unlabeled: Strain DKN1880 was used, and all expression and purification steps were the same as 
for the unlabeled SutA∆N protein. 
SutA∆N (15N): Strain DKN1879 was used, and all expression and purification steps were the same as for 
the SutA 46-101 (15N13C) protein, except glucose with the natural carbon isotope ratios was used at 4 
g/L.  
SutA∆C (15N): Strain DKN1880 was used, and all expression and purification steps were the same as for 
the SutA 46-101 (15N13C) protein, except glucose with the natural carbon isotope ratios was used at 4 
g/L. 640 
SutA BPA variants: E. coli BL21 DE3 was co-transformed with pEVOL-pBpF (Chin et al., 2002) and the 
plasmids from strains DKN1881-DKN1889 (pQE80L-6xHis-TEV-SutA amber mutants). Approximately 20 
colonies were scraped from the agar plate and grown at 33 °C in LB to OD600 = 0.6. Cultures were 
treated with 1 mM BPA (Iris-Biotech, Marktredwitz, Germany) and 1 mM IPTG and incubated in the dark 
for 20 h. Cells were pelleted and frozen at -80 °C. Pellets were resuspended in lysis buffer (40 mM 
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NaH2PO4, 300 mM NaCl, pH 8) containing 5 mM imidazole, 1 mg/mL lysozyme, and cOmplete mini 
protease inhibitor, EDTA free and lysed by probe sonication. The lysate was treated with Benzonase 
Nuclease on ice for 30 min and centrifuged. Following TEV cleavage, SutA fractions were pooled and 
loaded onto an Amicon 10 kDa centrifugal filter, and buffer exchanged to SutA storage buffer (25 mM 
Tris pH 8, 100 mM NaCl, 20% glycerol), and stored at -80°C. 650 
SutA FeBABE variants: Plasmids from strains DKN1890-DKN1892 were transformed into BL21(DE3) cells 
by electroporation. Expression and purification steps were the same as for the SutA∆N unlabeled 
protein.  
β1: Strain DKN1895 was used. An overnight culture was grown in LB plus 100 µg/ml carbenicillin and 10 
µg/ml gentamicin at 37 °C. The culture was diluted 1:100 into TB and grown for 3 hrs without antibiotics 
at 30 °C. The culture was cooled to 13 °C and expression was induced for 24 hrs with 400 µg/ml IPTG. 
Cell pellets were collected and frozen at -80 °C. Pellets were resuspended in a modified RNAP 
purification buffer (20 mM Tris pH 7.6, 5% glycerol, 3 mM 2-mercaptoethanol, 200 mM NaCl, 10 mM 
imidazole) plus 20 Kunitz units DNaseI and EDTA-free cOmplete mini protease inhibitor tablets (Roche) 
and lysed by passage through an EmulsiFlex-C3 (Avestin). Much of the expressed protein was not 660 
soluble, but the soluble fraction was  bound in batch to Ni-NTA beads, washed, eluted, and its TEV tag 
cleaved as described above, except TEV was used at a mass ratio of 1:25. Following TEV cleavage, the 
protein was concentrated to 1 ml in SEC buffer (30 mM Tris pH 7.6, 120 mM NaCl, 0.1 mM EDTA, 5% 
glycerol, 2.1 mM 2-mercaptoethanol) and passed over a HiLoad 16/600 Superdex 200 pg column. 
Fractions containing the protein of interest were collected and concentrated, and the glycerol 
concentration was brought to 20% before storage at -80 °C. 
70: Strain DKN1901 was grown overnight in LB containing 100 µg/ml carbenicillin, then diluted 1:1000 
into TB. After 4 hr growth, the culture was cooled to 16 °C and expression was induced with 400 µg/ml 
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IPTG for 18 hr. Cell pellets were collected, and lysis and purification was carried out as described for the 
RpoB B1 protein. 670 
S: Strain DKN1894 was used. Expression and purification were carried out as described for the 
unlabeled WT SutA, except TEV cleavage was not performed and an addition size exclusion step using a 
Superdex 200 column was added. Final protein storage buffer included 25 mM Tris pH 8, 100 mM NaCl, 
20% glycerol, and 2 mM β-mercaptoethanol. 
DksA: Strain DKN1893 was used. Expression and purification were carried out as described for the 
unlabeled WT SutA. 
70 ∆171-214: Strain DKN1902 was used. Expression and purification steps were carried out as for the 
full-length70. 
FeBABE conjugation. FeBABE was conjugated to the purified SutA S2C, S32C, and S98C proteins as 
described (Meares et al., 2003). Briefly, the purified proteins were de-metallated and fully reduced by 680 
incubating in a buffer containing 20 mM sodium phosphate pH 7.0, 100 mM NaCl, 20 mM EDTA, and 1 
mM DTT overnight. They were then buffer exchanged into conjugation buffer (20 mM MOPS pH 8.0, 100 
mM NaCl, 2 mM EDTA, 5% glycerol) using Amicon 3 kDa centrifugal filters, with care taken to reduce DTT 
concentrations to sub-micromolar levels. The concentration of free cysteines was measured using 
Ellman’s reagent (see below) and this measurement was used as the SutA concentration for the FeBABE 
variant proteins. SutA concentrations in the labeling reactions were 25-30 µM. The FeBABE reagent 
(Dojindo Molecular Technologies, Rockville MD) was dissolved in DMSO to 20 mM and added to a final 
concentration of 300 µM in a reaction volume of 1 ml. The reaction was incubated for 1 hr at 37°C and 
then quenched by dilution of the FeBABE reagent via dialysis into protein storage buffer (20 mM Tris, pH 
7.6, 100 mM NaCl, 20% glycerol, 0.1 mM EDTA). The concentration of free cysteines was measured again 690 
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using Ellman’s reagent to determine the efficiency of FeBABE conjugation, which was as follows: S2C 
variant (N-Fe): 57.4% labeled; S32C variant: 37.9%; S98C variant (C-Fe): 76.3%.  
Protein quantification. As we characterized SutA, it became clear that standard methods for protein 
quantification were very inaccurate for this protein, and that the degree and direction of the inaccuracy 
was different for the N- and C-terminal SutA mutants. This is likely due to the unusual amino acid 
composition of SutA compared to the bovine serum albumin (BSA) standard that is usually used for 
calibration in Bradford and BCA assays. We found that the Bradford assay (and coomassie staining of 
gels) greatly underestimated SutA concentration (likely due to a lack of aromatic amino acids and 
overabundance of acidic amino acids), and that the ∆C mutation exacerbated this problem by removing 
one of the two aromatic amino acids. The BCA assay slightly overestimated SutA concentration, likely 700 
due to the high accessibility of protein backbone, and this was also exacerbated in the ∆C protein, 
perhaps because a higher percentage of the remaining protein was the completely unstructured N-tail. 
Accordingly, we quantified the concentrations of our unmodified SutA proteins using total acid 
hydrolysis, derivatization of the resulting free amino acids, and HPLC as described below (Vendrell and 
Aviles, 1986). The FeBABE SutA variants were quantified using Ellman’s reagent to measure their free 
cysteines (one per protein) before FeBABE conjugation as described below. The BPA SutA variants were 
quantified using the BCA assay (Thermo Fisher) according to the manufacturer’s instructions, which was 
reasonably accurate for the full-length protein. All other proteins (RNAP core enzyme and β1 fragment, 
 factors, and DksA) were quantified using the Quick Start Bradford Protein Assay (Bio-Rad) with BSA as 
a standard. 710 
Ellman’s reagent assay: Ellman’s reagent (5,5-dithio-bis-(2-nitrobenzoic acid)) (Thermo Fisher) was 
dissolved in FeBABE conjugation buffer at 4 mg/ml. This stock was further diluted 1:50 into the buffer 
containing the protein to be assayed and distributed to the wells of a 96-well plate at 200 µl per well. 20 
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µl protein sample or cysteine hydrochloride monohydrate calibration standard was added, and 
absorbance at 412 nm was measured on a plate reader after incubation for 15 min at room 
temperature. 
Amino acid hydrolysis and HPLC: SutA proteins prepared for NMR, which were stored in 20 mM sodium 
phosphate, 100 mM NaCl buffer without glycerol, were used for quantification by amino acid hydrolysis. 
Subsequently, the concentrations of the glycerol stocks of the corresponding unlabeled proteins were 
determined by quantifying the intensity of Coomassie staining on an SDS-PAGE gel of the quantified 720 
NMR protein stocks and the glycerol stocks, run side by side. Vacuum hydrolysis of the SutA protein 
stocks was carried out by continuous boiling for 24 hr at 105 °C in 6 N HCl in a Thermo Scientific Pierce 1 
ml vacuum hydrolysis tube (Thermo Fisher), according to the manufacturer’s instructions. After 
hydrolysis, the protein was dried in vacuo and resuspended in 100 µl 150 mM NaHCO3 pH 9.0. 100 µl 15 
mM dabsyl chloride (Sigma) in acetonitrile was added and the samples were incubated at 70 °C for 15 
min. The reaction was quenched by the addition of 800 µl of a 1:1 mixture of ethanol and water.  Debris 
were removed by centrifugation at top speed in a microfuge and the sample was transferred to an HPLC 
vial. 5 µl of the sample was injected onto a Waters Alliance HPLC system, composed of an e2695 
separation module, 2998 PDA detector, and Acquity QDa detector, and fitted with a 3x100 mm XBridge 
BEH C18 reversed-phase chromatography column, 2.5 µm particle size. Buffer A contained 0.04% NH4OH 730 
in water, and Buffer B contained 0.04% NH4OH in acetonitrile. Each sample was loaded onto the column 
in a mixture of 8% buffer B and 92% buffer A, and a gradient from 8-30% buffer B was run over 40 min, 
followed by a gradient from 30-90% buffer B over 10 min. The column was then cleaned for 2 min with 
90% buffer B, and returned to 8% buffer B over 8 min. A 2.5 mM amino acid standard mix in 0.1 N HCl 
(Sigma) was subjected to the same hydrolysis and derivatization protocol and used to calibrate amino 
acid peak areas. The identity of each peak was confirmed by mass spectrometry. Quantifications of 
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alanine, glycine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, and serine were 
averaged for each sample to estimate the concentration of the SutA variant.  
NMR experiments  
Proteins were purified as described above. Except where noted, protein concentrations were 300 µM 740 
and the buffer contained 20 mM sodium phosphate, pH 7.0, 100 mM sodium chloride, and 10% D2O. 
46-101: 2D and 3D NMR spectra were collected on a Varian Inova 600 MHz NMR with a triple resonance 
inverse probe running VnmrJ 4.2A. The optimal temperature for minimizing the linewidth of 15N HSQC 
peaks was found to be 7 °C. Although SutA was stable in solution at fairly high concentration at a range 
of temperatures, the peaks showed concentration-dependent broadening that was only alleviated by 
decreasing the concentration and acquiring the spectra below ambient temperature. The following 
spectra were acquired: 15N HSQC, 13C HSQC, HNCO, HNCA, HNCACB, CBCACONH, HNCOCA, HNCACO, 
CCONH, and 15N HSQC experiments modified for measurement of T2 and of 
15N-1H NOE. These 
experiments were all done with standard Varian/Agilent pulse programs included in the Biopack 
extension of VnmrJ. The processed spectra were imported into the CcpNmr Analysis program (Vranken 750 
et al., 2005), and Assign-derived peak lists from the spectra were submitted to the PINE web server 
assignment program maintained by NMRFAM at the University of Wisconsin, pine.nmrfam.wisc.edu 
(Bahrami et al., 2009). Assignments proposed by the PINE output were validated or corrected in the 
Analysis software. 
Full-Length SutA: Spectra were acquired at 7 °C on a Bruker AV III 700 MHz spectrometer with a TCI 
cryoprobe running Topspin 3.2. The spectra (15N HSQC, 13C HSQC, HNCACB, and CBCACONH) were all 
acquired with standard Bruker pulse programs. 15N HSQC experiments modified for measurement of T2 
and of 15N-1H NOE were performed on a Varian Inova 600 MHz NMR with a triple resonance inverse 
probe running VnmrJ 4.2A, at 7 °C, with standard Varian/Agilent pulse programs included in the Biopack 
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extension of VnmrJ. Standard 15N HSQC spectra were also collected at 7 °C, 16 °C and 25 °C. The spectra 760 
were imported into CcpNmr Analysis and partially assigned via the PINE web server as described 
previously.  
Additional 15N HSQC experiments: 15N HSQC spectra for the SutA ∆N and SutA ∆C SutA proteins were 
collected on a Varian Inova 600 MHz NMR with a triple resonance inverse probe running VnmrJ 4.2A, 
with standard Varian/Agilent pulse programs included in the Biopack extension of VnmrJ, to test 
whether the truncations influenced the overall structure of the protein.  
Stretched gel preparation for residual dipolar coupling measurements: 15N13C-labeled SutA was 
embedded in a stretched polyacrylamide gel using the “Gel NMR Starter Kit” (cat. #NE-373-B-5.4/4.2, 
New Era, Vineland NJ), according to the manufacturer’s instructions. Briefly, a cylindrical 8% 
polyacrylamide gel of about 300 µl, with a diameter of 5.4 mm (29:1 acrylamide:bisacrylamide ratio) was 770 
prepared. After polymerization, the gel was dialyzed 3 times against nanopure water, then dried 
overnight at 37 °C, and then returned to the cylindrical chamber in which it was cast. 300 µl 15N13C-
labeled SutA at a concentration of 300 µM in a buffer containing 20 mM sodium phosphate, pH 7.0, 100 
mM sodium chloride, and 10% D2O was added to the dried gel and allowed to soak into it overnight at 
room temperature. The SutA-impregnated gel was then pushed into an NMR tube with a diameter of 4.2 
mm, resulting in its stretching. Spectra were collected on a Varian Inova 600 MHz NMR with a triple 
resonance inverse probe running VnmrJ 4.2A. To extract 1J(15N, 1H) coupling constants, the pulse 
sequence gNhsqc_IPAP was used to acquire the in-phase and antiphase spectra alternately. The sum 
and difference spectra were generated in VnmrJ with appropriate 2D transform coefficients and 
imported into CcpNmr Analysis for overlay with the conventional 15N HSQC spectrum. 780 
NMR binding experiment: 15N-labeled SutA and β1 fragment purified as described above were buffer 
exchanged into 20 mM sodium phosphate, pH 7.0, 100 mM sodium chloride, at an approximate 
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concentration of 30 µM each. To increase the chances that most of the SutA would be bound to β1 
fragment, the mixture was run over a HiLoad Superdex 200 pg size exclusion column (GE Healthcare Life 
Sciences, Marlborough MA) and fractions representing the complex were retained and concentrated to 
270 µl before adding D2O to 10%. The final concentration of the complex was approximately 25 µM. In 
addition, 15N-labeled SutA was mixed with S at 50 µM each and buffer exchanged into 20 mM sodium 
phosphate, pH 7.0, 100 mM sodium chloride, and 10% D2O. 
15N HSQC spectra were acquired on a Bruker 
800 MHZ AV III HD spectrometer with a TCI cryoprobe at 25 °C using the standard Bruker pulse sequence 
hsqcetfpf3gpsi. 790 
Data analysis: Secondary shifts were calculated by the TALOS software package as part of the PINE 
output. RDC values were evaluated manually by comparing the overlaid sum and difference spectra in 
the CcpNmr Analysis Suite, and the presence or absence of a peak in the positive (1H-15N) NOE was also 
evaluated manually for each assigned residue in the CcpNmr Analysis Suite. R2 values were calculated by 
fitting a single exponential to the series of peak integral values collected with different T2 relaxation 
times for each assigned residue. To generate structural models based on the chemical shift and RDC 
values we collected, these values were uploaded to the Robetta Fragment Server (Kim et al., 2004), and 
3- and 9-residue fragment libraries were picked. Each library contained 200 fragments per SutA amino 
acid position. Using these fragment libraries, 16,000 decoy structures were generated using the 
PyRosetta suite (Chaudhury et al., 2010), following a folding protocol based on the PyRosetta folding 800 
tutorial published by the Gray lab (Bradley et al., 2005). Briefly, the SutA protein sequence was set to a 
linear structure, then 1000-1500 cycles of fragment insertion and energy minimization were performed 
to generate each decoy. Each cycle consisted of 3 short fragment (3 residues) and 1 long fragment (9 
residues) insertions, followed by a low-resolution Monte Carlo scoring. As is perhaps unsurprising for a 
protein that has large regions of intrinsic disorder, the decoys did not converge to a single family of 
lowest-energy structures. We calculated the RMSD for each decoy compared to an ab initio structural 
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prediction for SutA that was produced by the Robetta Server (Kim et al., 2004). In general, decoys with 
lower RMSDs compared to this ab initio prediction also contained some version of the α helix that is 
supported by our NMR data; some other decoys (and some with the lowest energy scores) did not have 
the α helix. We arbitrarily chose several decoys to show a range of conformations that SutA might 810 
adopt; the strongest predictions of our NMR data are that residues 56-76 adopt an α-helix secondary 
structure and that the N- and C-tails are disordered, and all of the chosen models conform to those 
predictions. To color the model shown in Figure 1D according conservation, the alignment shown in 
Figure 1 Supplement 1 was opened in Chimera (Pettersen et al., 2004), and the “Render by 
conservation” function was used.    
In vitro transcription experiments  
Experiments were carried out broadly as described in (Artsimovitch and Henkin, 2009). In general, RNAP 
holoenzyme was prepared by mixing core enzyme with a 3-fold (70) or 5-fold (s) excess of  factor and 
incubating for 15 min at 37 °C. dsDNA templates were prepared by PCR from plasmids carrying the 
relevant promoter sequences or directly from Pseudomonas aeruginosa UBCPP-PA14 genomic DNA, 820 
using the Kappa high-fidelity hot-start 2x master mix according to the manufacturer’s instructions (see 
strain and primer tables for plasmid and primer details). PCR products were checked by electrophoresis 
on 2% agarose gels to ensure that they consisted of a single product, purified from primers and residual 
dNTPs using the DNA Clean and Concentrator kit (Zymo Research, Irving CA), and quantified by 
NanoDrop (Thermo Fisher). The rrn bubble template was prepared by annealing the template strand 
and non-template strand oligos as follows: 80-mer oligos (Integrated DNA Technologies) were 
resuspended at a concentration of 100 µM in 0.1x TE and mixed together in 10X annealing buffer to give 
final concentrations of 45 µM duplex, 10 mM Tris-Cl ,100 mM NaCl, and 1 mM EDTA, then heated to 95 
°C for 5 min and allowed to cool from 95 °C to 70 °C at a rate of 0.1 °C/ second, incubated at 70 °C for 20 
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min, then allowed to cool to 22 °C at a rate of 0.1 °C/second.  All pre-incubations and reaction 830 
incubations took place at 37 °C, and all reactions used TGA buffer (20 mM Tris-acetate pH 8.0, 2 mM Na-
acetate, 2 mM Mg-acetate, 4% glycerol, 0.1 mM DTT, 0.1 mM EDTA). Water used in reaction and 
running buffer preparation was treated with diethyl pyrocarbonate (DEPC). Reactions were quenched 
with an equal volume of urea stop buffer (8 M urea, 10 mM EDTA, 0.8x TBE, 2 mg/ml bromophenol blue, 
2mg/ml xylene cyanol FF, 2 mg/ml amaranth), and heated to 95 °C for 2 min immediately before gel 
loading. 20% acrylamide denaturing Urea-TBE gels were prepared using the Sequa-gel system (National 
Diagnostics) according to the manufacturer’s instructions except TBE was added to 0.5x instead of 1x. A 
60-well comb was used and gels were run using the Owl S3 vertical sequencing gel system (Thermo 
Fisher). 2 µl sample was loaded per lane. After electrophoresis, one glass plate was removed and the gel 
was covered with plastic wrap and exposed directly to the phosphorimager screen (Molecular dynamics) 840 
for 12-48 hr. 
Single turnover initiation experiments: For SutA titrations on the rrn and bcn promoters, reactions were 
assembled as follows: RNAP holoenzyme (20 nM final concentration), DNA template (15 nM final 
concentration), TGA buffer, and water were mixed in a volume of 3 µl and added to 1 µl SutA (at 5x the 
final concentration) or storage buffer on ice. These 4 µl reactions were incubated for 6 min to allow 
open complex to form. 1 µl NTP mix (375 µM initiating dinucleotide, 250 µM each NTP not carrying 32P 
label (ATP, UTP, and either CTP or GTP), 100 µM cold NTP of the same type as that carrying the label 
(either CTP or GTP), 0.75 µCi α32P GTP or CTP (3000 Ci/mmol, 10 mCi/ml, Perkin Elmer, Waltham MA), 
and 100 µg/ml heparin) was added and transcription was allowed to continue for 8 minutes before 
reactions were quenched.  Initiating nucleotides were CpU for the rrn promoter and ApC for the bcn 850 
promoter (IBA Lifesciences, Göttingen, Germany). For the pepB promoter, 40 nM ES was and the 
transcription reactions were allowed to proceed for 16 min in an effort to ensure sufficient signal. The 
final NaCl concentration in these reactions (due to NaCl in protein storage buffers) was 26 mM for the 
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rrn and bcn promoters and 32 mM for the pepB promoter. For the iNTP titration experiments, no 
dinucleotides were included, and instead the NTP mix contained 50, 500, or 5000 µM CTP and UTP (for 
the 10, 100, and 1000 µM iNTP conditions), 250 µM ATP, 100 µM GTP, and 0.75 µCi α32P GTP per 1 µl 
NTP mix.  For the DksA/ppGpp experiments, 0.5 µl 5 µM SutA (or 0.5 µl storage buffer) and 0.5 µl of a 
mixture containing 2.5 µM DksA and 25 µM ppGpp (Sigma) in storage buffer (or 0.5 µl storage buffer) 
were distributed to tubes. The remainder of the experimental set-up was the same as for the SutA 
titration experiments.     860 
Multiple turnover initiation experiments (bubble template): Reactions were assembled and run as 
described above for single turnover assays, but no heparin was included in the NTP mix. This was to 
allow both abortive and processive initiation to occur according to their natural rates in a multiple 
turnover context, since complexes leading to abortive initiation are heparin resistant and thus abortive 
initiation would occur in a multiple turnover context regardless of heparin addition. 
Open complex stability assays: A 7x reaction master mix containing RNAP holoenzyme (for 20 nM final 
concentration in transcription reactions) template (15 nM final), SutA at the indicated concentration, or 
storage buffer and water in a volume of 27.5 µl was mixed on ice. 1 µl NTP mix (at the same 
concentrations as described for single turnover reactions, but without heparin) was distributed to each 
of 6 reaction tubes. The reaction master mix was incubated for 6 min to allow open complex to form, 870 
and then 0.5 µl of heparin at 1.5 mg/ml was added. Immediately, 4 µl of the master mix was removed 
and added to 1 µl NTP mix for the time 0 point. At the indicated time points after the addition of 
heparin, additional 4 µl aliquots were removed and added to tubes containing 1 µl NTP mix. Each 
reaction was quenched 8 min after mixing the reaction mix with the NTP mix.  
Gel image acquisition and analysis: Phosphorimager screens were scanned on a Typhoon FLA 9000 gel 
imaging system (GE Healthcare Life Sciences), at the maximum PMT setting and with each pixel 
.CC-BY-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/423384doi: bioRxiv preprint first posted online Sep. 20, 2018; 
39 
 
representing 200 µm. Images were analyzed using the gel lane analysis tool of the FIJI open-source 
image analysis suite (Schindelin et al., 2012). First, images were rotated, background-subtracted, and 
contrast-adjusted (ensuring that no pixels were saturated), then pixel densities in the relevant regions of 
each lane were plotted, and the areas under each peak quantified. For the SutA titration experiments, 2-880 
3 bands spanning a length range of about 4-8 nucleotides represented the run-off transcripts (RNAP 
terminates inefficiently on a linear transcript, sometimes producing multiple bands), and all of the major 
bands in this range were quantified (the ratios of each band to the total were not generally affected by 
SutA). The most prominent higher band likely represents the product of transcription initiating at one 
end of the linear transcript and running to the other end, and was ignored. For the iNTP titrations, the 
major products were the same as those seen for initiation with the CpU dinucleotide, but at the highest 
[iNTP], additional bands within the 8 nucleotide range appeared, and all bands in this range were 
quantified. For initiation on the bubble template, abortive products were much more prominent, and 
their relative abundances were affected by the  used. In order to calculate a value representing the 
number of initiation events, all major bands in each lane were quantified and the signal intensity for 890 
each band was divided by the number of G bases in the sequence corresponding to that band to obtain 
a value proportional to the number of transcripts represented by the band. The sum of the values for 
each band in the lane was used as a measure of the total number of transcripts initiated. Whenever 
possible, values were normalized and compared within the same gel. Where comparisons across gels 
were necessary, values from each gel were normalized to the values obtained for reactions containing 0 
nM SutA and E70 on that gel. 
Transcription start site mapping: P. aeruginosa UCBPP-PA14 culture was collected in mid-exponential, 
early stationary, and late stationary phases, cells were pelleted, and pellets were frozen in liquid 
nitrogen. RNA was extracted from the pellets using the RNeasy kit (Qiagen, Hilden, Germany) according 
to the manufacturer’s instructions. Genomic DNA was depleted using the Turbo DNA-free kit 900 
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(Ambion/Invitrogen, Carlsbad CA) according to instructions. cDNA corresponding to the 5’ ends of 
nascent rRNA transcripts was generated by reverse transcription using 10 µg total RNA, 4 pmol rRNA-
specific primer, 500 µM dNTPs, 5µM DTT, 1x reverse transcriptase buffer, and 300 units SuperScript 
reverse transcriptase in a 40 µl reaction. Primer binding was allowed to occur for 5 min at 65 °C, then 
the reverse transcriptase was added and the reaction allowed to proceed for 45 min at 55°C, then the 
reaction was stopped by incubation for 15 min at 70 °C. 2 units RNaseH were added and the reactions 
were incubated at 37 °C for 20 min to degrade RNA-DNA hybrids, and the cDNA was cleaned up using 
the Qiaquick PCR clean-up kit (Qiagen). Poly-T tails were added to the 3’ ends of the cDNA using 
terminal transferase (Promega) according to instructions. The resulting T-tailed cDNA was then used as a 
template in a first round PCR reaction with a primer against the rRNA transcript and one against the 910 
poly-T tail that adds an additional specific sequence. This PCR product was then used as the template in 
a second round PCR reaction with primers against the rRNA transcript and the newly added specific 
sequence that was part of the primer in the first round PCR. Two different DNA polymerases were tried 
(GoTaq, Promega; or Q5, NEB), according to instructions, and gave similar results (Figure 2, – figure 
supplement 2). The resulting PCR products from the stationary phase time points were cloned into the 
pUC18 plasmid using Gibson assembly and approximately 40 individual clones were sequenced. Many of 
the products turned out to represent the site that is cleaved by RNAse III in the first step of 16S rRNA 
maturation, which is very similar in sequence and distance upstream of the mature 16S rRNA start 
(Steitz and Young, 1979) to the E. coli rrn RNAse III cleavage site (these correspond to the strong, lowest 
band in Figure 2 – figure supplement 2). However, a number of the products corresponded to the 920 
proximal putative transcription initiation site (second lowest band) and most of these initiated at the 
cytidine 8 bp downstream of the -10 motif, although a few also initiated at a cytidine 7 bp downstream 
of the -10 motif. Although we detected some fainter bands potentially corresponding to start sites 
further upstream, we were unable to recover any sequences corresponding to these start sites, even 
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after the higher faint bands were gel-purified before cloning into pUC18. We also tested a promoter 
corresponding to  the next putative start site upstream of this start site in vitro and found that it drove 
initiation more weakly than the proximal start site (data not shown). Together, these data suggest that 
this proximal start site is the dominant one in P. aeruginosa, at least under the conditions we 
investigated.       
qRT-PCR: For all experiments, total RNA was extracted from frozen cell pellets using the RNeasy kit 930 
(Qiagen), genomic DNA was removed using the Turbo DNA-free kit (Ambion/Invitrogen), cDNA was 
generated using the iScript reverse transcriptase kit (Bio-Rad), and qPCR reactions were carried out 
using the iTaq Universal SYBR Green Supermix (Bio-Rad) in an Applied Biosystems 7500 Real-time PCR 
system, all according to instructions. For experiments comparing rrn expression in E. coli and P. 
aeruginosa, either the empty vector pMQ72 or pMQ72 carrying sutA under control of the pBAD 
arabinose-inducible promoter was transformed into the ∆sutA strain of P. aeruginosa UBCPP-PA14 or E. 
coli MG1655 by electroporation (see strains). Overnight cultures in LB plus 100 or 20 µg/ml gentamicin 
respectively were diluted into fresh LB plus 20 mM arabinose and allowed to grow for 16 hr into 
stationary phase before harvesting cells and freezing cell pellets in liquid nitrogen. Nascent rrn 
transcripts were measured using primers that hybridize to the leader region upstream of the start of the 940 
16S rRNA gene, which is degraded during ribosome maturation, and normalized to hcaT transcripts in E. 
coli (Zhou et al., 2011) or to oprI transcripts in P. aeruginosa (see primers). Standard curves relating the 
primer efficiencies of the rrn and control genes were generated using genomic DNA from the respective 
organisms. oprI is a much more abundant transcript than hcaT, resulting in lower normalized values for 
the P. aeruginosa rrn transcript than for the E. coli normalized transcript. For experiments evaluating the 
effects of WT or mutant SutA on expression of rrn, pepB, or bcn in vivo, in the presence or absence of 
rpoS, constructs for expressing WT or mutant sutA under the control of the pBAD arabinose-inducible 
promoter were integrated into the attB site of the P. aeruginosa chromosome, in the ∆sutA strain, so 
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that arabinose-induced SutA expression was the only source of SutA in these strains. Additionally, the 
WT sutA construct was introduced into the attB site of a ∆rpoS∆sutA strain. These strains were grown 950 
overnight in LB, then diluted 1:1000 into minimal medium containing 40 mM pyruvate as a sole carbon 
source, and either containing 20 mM arabinose or not. The pyruvate minimal medium cultures were 
allowed to grow for 24 hr, during which they slowly reached stationary phase (pyruvate minimal 
medium imposes a doubling time of approximately 4 hr), and then cells were harvested and cell pellets 
were frozen in liquid nitrogen. Primers for the rrn transcript were to the leader region of the transcript 
as described above, and primers for pepB and bcn were directed against the coding sequence of those 
genes. These transcripts of interest were normalized to oprI transcript levels using standard curves 
generated from genomic DNA.  
 
Cross-linking and Affinity Cleavage 960 
BS3 cross-linking: Bis(sulfosuccinimidyl) suberate (BS3) d0 and d4 isotopologs were purchased from 
Thermo Scientific. RNAP and SutA were mixed in a 1:10 molar ratio (0.5 µM RNAP, 5.0 µM SutA) in 10 
mM HEPES pH 8, 100 mM potassium acetate and incubated on ice for 1.5 hr. Cross-linking was initiated 
by addition of 5 mM of a 4:1 molar ratio of BS3 d0:d4 and the reaction was incubated on ice for 2 hr. 
Cross-linking was quenched by addition of ammonium bicarbonate to a final concentration of 50 mM. 
Proteins were digested in solution by incubation with 500 ng GluC overnight at 37 °C. Digestion was 
quenched by addition of 5% formic acid. Digested peptides were desalted by HPLC using a C8 microtrap 
(Optimize Technologies, Oregon City OR), using a gradient of buffer A: 0.2% formic acid in H2O and 
buffer B: 0.2% formic acid in acetonitrile) and concentrated in vacuo. Samples were resuspended in 0.2% 
formic acid and analyzed on the Orbitrap Elite Hybrid Ion Trap MS equipped with an Easy 1000 970 
nanoUHPLC (Thermo Scientific). Solvent A consisted of 97.8% H2O, 2% ACN, and 0.2% formic acid and 
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solvent B consisted of 19.8% H2O, 80% ACN, and 0.2% formic acid. Digested peptides were directly 
loaded at a flow rate of 500 nL/min onto a 16-cm analytical HPLC column (75 μm ID) packed in-house 
with ReproSil-Pur C18AQ 3 μm resin (120 Å pore size, Dr. Maisch, Ammerbuch, Germany). The column 
was enclosed in a column heater operating at 45 °C. After 30 min of loading time, the peptides were 
separated with a 50 min gradient at a flow rate of 350 nL/min.  The gradient was as follows: 2% B for five 
min, 2–40% B (60 min), and 100% B (10 min). The Orbitrap was operated in data-dependent acquisition 
mode to automatically alternate between a full scan (m/z=300–1600) in the Orbitrap and subsequent 5 
HCD MS/MS scans in the Orbitrap. Normalized collision energy was 30% and activation time was 100 ms. 
Resolution on MS was set to 120,000 and MS/MS was 15,000. The experiment was performed with two 980 
replicates.  
Raw files were first searched using MaxQuant to identify precursor mass pairs, differing by 4.02 Da, that 
represent cross-links made by both of the BS3 linker isotopologs. Raw files were converted to peak lists 
with ProteoWizard (Kessner et al., 2008) and subset for only those spectra that were identified as mass 
pairs. Subset peak lists were analyzed with Protein Prospector online, version 5.12.4, following reported 
protocols with modifications below (Trnka et al., 2014). The protein database contained the sequences 
for purified SutA, RpoA, RpoB, RpoC, RpoD, and RpoZ. 80 peaks from each spectrum were searched 
using a tolerance of 10 ppm for precursor ions and 25 ppm for product ions. Enzyme specificity was 
GluC, and up to two missed cleavages per peptide were allowed. Carbamidomethylation of cysteines 
was specified as a constant modification, and protein N-terminal acetylation, oxidation of methionine, 990 
and dead-end modification with the cross-linker at lysine positions and protein N-termini were set as 
variable modifications. Additionally, incorrect monoisotopic peak assignments were considered as 
variable modifications. The analysis was run twice for each set of peak lists to search for both cross-
linker isotopologs.  
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For cross-links detected between RNAP proteins, we used a reported structural model of the E. coli 
RNAP complex (PDB: 3LU0) to calculate the inter α-carbon distance between amino acids (Opalka et al., 
2010). We used this calculated distance as a metric to distinguish “quality” cross-links from all others. 
Based on the length of the linker, the maximum inter α-carbon distance between lysines cross-linked by 
BS3 is 24.6 Å, so we considered cross-links with distances near or below this value to be reasonable. Like 
the study by Trnka et al., we found Score Difference to be the best discriminant for making this 1000 
distinction. A Score Difference cutoff of 8.0 (similar to the value of 8.5 found by Trnka et al.) separated 
high-distance and low-distance cross-links (Figure 3 supplement). The final criteria for assigning quality 
cross-links were: (i) found as a precursor mass pair and (ii) Score Difference greater than 8.0. These 
cross-links were aggregated to determine the number of spectra from each replicate and the maximum 
Score Difference for each amino acid linkage (Figure 3 supplement). To visualize cross-link spectra, peak 
lists subset for matched pairs were analyzed by StavroX (Götze et al., 2012) using the same settings 
described for Protein Prospector. The best spectra used to match the cross-links between SutA and 
RNAP are shown in Figure 3 supplement. 
BPA cross-linking for LC-MS/MS analysis: 20 µl cross-linking reactions contained 500 nM core RNAP, 2 
µM SutA (BPA54 or BPA84 variant), 100 mM NaCl, and TGA buffer (4% glycerol, 20 mM Tris-acetate pH 1010 
8.0, 2 mM sodium acetate, 2 mM magnesium acetate, 100 µM DTT, and 100 µM EDTA). Complexes were 
allowed to form for 6 min at 37 °C and were then UV-irradiated for 1 min at 1W/cm2 using the Omnicure 
S2000 lamp (Excelitas, Waltham MA). Cross-linked complexes were dried in vacuo, resuspended in 40 µl 
8 M urea and 100 mM Tris-HCl, reduced with 3 mM TCEP, alkylated with 10 mM iodoacetamide, 
digested with 100 ng lysyl endopeptidase for 4 hr, and then digested with 500 ng trypsin overnight in 2 
M urea and 1 mM CaCl2.  Formic acid was added to 5% and then the sample was desalted by HPLC using 
a C8 microtrap (Optimize Technologies), with a gradient of buffer A: 0.2% formic acid in H2O and buffer 
B: 0.2% formic acid in acetonitrile), concentrated in vacuo, and resuspended in 0.2% formic acid. 
.CC-BY-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/423384doi: bioRxiv preprint first posted online Sep. 20, 2018; 
45 
 
Samples were resuspended in 0.2% formic acid and run on the Q Exactive HF Orbitrap MS, equipped 
with an Easy 1200 nanoUHPLC (ThermoFisher Scientific). Solvent A consisted of 97.8% H2O, 2% ACN, and 1020 
0.2% formic acid and solvent B consisted of 19.8% H2O, 80% ACN, and 0.2% formic acid. Digested 
peptides were directly loaded at a flow rate of 220 nL/min onto a 20-cm analytical HPLC column (50 μm 
ID) packed in-house with ReproSil-Pur C18AQ 1.9 μm resin (120 Å pore size, Dr. Maisch, Ammerbuch, 
Germany). The column was enclosed in a column heater operating at 65 °C. After 45 min of loading time, 
the peptides were separated with a 60 min gradient at a flow rate of 220 nL/min.  The gradient was as 
follows: 2–6% B (4 min), 6-25% B (41 min), 25-40% B (15 min), and 100% B (10 min). The Orbitrap was 
operated in data-dependent acquisition mode to automatically alternate between a full scan (m/z=300–
1650) in the Orbitrap and subsequent 7 HCD MS/MS scans. Normalized collision energy was 28 and max 
injection time of 250 ms. Resolution on MS was set to 60,000 and MS/MS was 30,000. Raw files were 
converted to mzXML files by msConvert (Adusumilli and Mallick, 2017) and analyzed using StavroX 1030 
(Götze et al., 2012) with a precursor and fragment ion tolerance of 5 ppm and a 1% FDR. 
FeBABE cleavage experiments: FeBABE cleavage experiments were based on protocols described in 
(Meares et al., 2003).Our initial determination of SutA-FeBABE cleavage sites (as shown in Figure 3) 
utilized a large-format gel and Western blotting apparatuses (16x16 cm) to allow for higher resolution in 
calculating the cleavage site. 20 µl Reactions contained 250 nM RNAP (E, ES, or E70), 250 nM rrn 
template, 2 µM SutA (WT or FeBABE variant), 100 mM NaCl, in 1x TGA buffer (yielding a final glycerol 
concentration of 8% including enzyme storage buffers). Holoenzyme complexes were formed by mixing 
a 3-fold molar excess of S or 70 with E and incubating at 37 °C for 15 min. After assembling the rest of 
the reaction mixture, it was incubated at 37 °C for 10 min. to allow SutA and DNA-containing complexes 
to form, and then cleavage was initiated by the addition of 2.5 µl 50 mM sodium ascorbate, 10 mM 1040 
EDTA then 2.5 µl 50 mM hydrogen peroxide (J.T. Baker Ultrex grade (Avantor, Radnor PA)), 10 mM 
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EDTA. Reactions were incubated for 7 min and then quenched by the addition of 8.3 µl 4x LDS loading 
buffer (Bio-Rad, Hercules CA).  
FeBABE protein cleavage reactions of open complexes: containing different  factors and promoter 
DNA were carried out on a smaller scale for SDS-PAGE and western blotting on mini gels, which allowed 
for more efficient transfer. 10 µl reactions contained 100 nM RNAP, 100 nM template, 2µM SutA, and 
100 mM NaCl, in 1x TGA buffer, and sodium ascorbate, hydrogen peroxide, and loading buffer were 
added to the same final concentrations as described above. 
 FeBABE DNA cleavage reactions: were also 10 µl but contained 100 nM RNAP, 15 nM template DNA, 
and 2 µM SutA in 1x TGA buffer. The final NaCl concentration in these reactions (derived from the 1050 
protein storage buffers) was 40 mM. The reactions were quenched by the addition of 37.5 µl 100 mM 
thiourea, then treated with proteinase K, ethanol precipitated, and subjected to primer extension, 
before running them on Urea-TBE denaturing PAGE gels as described below for KMnO4 footprinting.     
SDS-PAGE and Western blotting  
For FeBABE initial large-format gels, markers for calibrating the observed cleavage positions were 
generated by cloning C-terminal fragments of β (aa 355-1357, 450-1357, 520-1357, 626-1357, and 1062-
1357) into the pQE80L expression vector, and transforming into E. coli (see strain list). 5 ml cultures of 
these strains in LB were grown to late exponential phase and high levels of expression were induced by 
incubating with 1 mM IPTG for 4 hr. 100 µl aliquots of these cultures were pelleted by centrifugation 
and stored at -80 °C. Pellets were resuspended in 25 µl BugBuster (Novagen) and mixed together as 1060 
follows: for 6% gels, 2 µl each of fragments 355, 450, and 520, plus 12 µl of fragment 626 were brought 
to a final volume of 200 µl 1x SDS loading buffer, and 10-15 µl were loaded; for 8% gel, 36 µl 1062 
fragment was added to the mixture. 6% or 8% Tris-glycine-SDS gels were cast in the PROTEAN II xi Cell 
system using a 19:1 acrylamide: bisacrylamide mixture (Bio-Rad). Samples were denatured by heating in 
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LDS sample buffer for 5 min at 80 °C and 1 mM DTT was added to the upper buffer to minimize protein 
oxidation during the 6-8 hr run time at 150 V. Following electrophoresis, gels were stained with Instant 
Blue colloidal Coomassie stain (Expedeon, San Diego CA) for 1 hr, briefly rinsed in water, and transferred 
to a nitrocellulose membrane using 1x Towbin transfer buffer containing 20% methanol and 0.03% SDS, 
for 4-6 hr at 250 mA using a Hoefer TE62 transfer apparatus (Hoefer, Holliston MA). Membranes were 
blocked for 1 hr in 2.5% non-fat dry milk in TBST, then incubated in primary antibody (EPR18704, Abcam, 1070 
Cambridge MA) at a 1:1500 dilution for 8 hr, washed in TBST and incubated in the secondary antibody 
(goat anti-rabbit HRP, Sigma, St. Louis) at a dilution of 1:5000 for 1 hr before washing in TBST and 
developing with SuperSignal™ West Pico PLUS Chemiluminescent Substrate (ThermoFisher, Waltham 
MA) according to instructions.  Blots were exposed to x-ray film for 5-15 min. For the FeBABE reactions 
to analyze the effects of different  factors and DNA templates, samples were run on 4-20% gradient 
Tris-glycine SDS mini-gels (Bio-Rad) for 1 hr. at 150 V, then stained with Coomassie Colloidal Blue and 
transferred to pre-cut nitrocellulose membranes (Bio-Rad) for 8 hr at 20 V in 1X Towbin transfer buffer 
without methanol or SDS added. The membranes were cut to separate region containing the uncleaved 
β subunit band from the region containing the cleavage products, which were of much lower 
abundance. Western blotting for the membrane region containing the cleavage products was the same 1080 
as described above for the large-format gel, but the region containing the uncleaved band was 
incubated with primary antibody diluted 1:2000 and secondary antibody diluted 1:20,000. The two 
regions of the membrane were then placed next to each other for exposure to X-ray film. The cutting of 
the membrane occasionally resulted in the appearance of a second band immediately below the 
uncleaved band (especially in the outer lanes of the gel), which was just the edge of the uncleaved band. 
For analysis and Western blotting of BPA cross-linking in various holoenzyme/DNA contexts, reaction 
volumes were 10 µl and contained 100 nM RNAP core or holoenzyme, the concentrations of the BPA54 
variant listed in the figures, 100 nM template DNA, 100 mM NaCl, and TGA buffer. Cross-linking was 
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carried out as described above for LC-MS/MS analysis, and then samples were added to LDS loading 
buffer. 3-8% Tris-acetate gels and Tris-acetate-SDS running buffer (NuPAGE) were used to maximize 1090 
separation of the cross-linked β+SutA band from the uncross-linked β only band. Subsequent steps of 
the Western blotting protocol were the same as for the FeBABE mini-gels, using the same antibody 
dilutions as for the uncleaved portion, described above. 
KMnO4 footprinting and FeBABE DNA cleavage analysis  
Footprinting was carried out essentially as described in (Kahle and Paule, 2009). Briefly, 10 µl reactions 
containing 100 nM RNAP holoenzyme, 15 nM template DNA, and the amounts of SutA or SutA mutant 
indicated in the figures in 1x TGA buffer were incubated for 6 min to allow complexes to form and then 
1 µl of 110 mM KMnO4 was added and the oxidation reaction was allowed to proceed for 5 min. 
Reactions were quenched by the addition of 1 µl 1 M 2-mercaptoethanol. Reaction volumes were 
brought to 50 µl with water and then 50 µl of a solution of 0.2% SDS and 2 mg/ml proteinase K was 1100 
added and the reactions were incubated for 1 hr at 50 °C. 1 µl of linear acrylamide at a concentration of 
10 mg/ml (as a carrier for nucleic acid precipitation), 10 µl of 3 M sodium acetate pH 5.2, and 275 µl of 
ethanol were added and DNA was precipitated overnight.  Nucleic acid pellets were washed once with 
70% ethanol, dried, and resuspended in 8 µl water. 12.5 µl primer extension reactions contained 10 mM 
Tris, 50 mM KCl, 1.5 mM MgCl2, 5% DMSO, 2 M betaine, 250 µM dNTPs (TaKaRa, Kusatsu, Shiga 
Prefecture, Japan), 2.5 pmol Cy3 or Cy5 labeled primer (Integrated DNA Technologies, Coralville IA), 2.5 
µl template, and 1 unit (0.2µl) Taq polymerase (NEB, Ipswich MA). After heating to 95 °C for 3 min, 15 
cycles of 30 seconds at 95 °C, 30 seconds at 53 °C, and 30 seconds at 72 °C were carried out, followed by 
a final 3 min incubation at 72 °C. Reactions were mixed with an equal volume of formamide loading 
buffer (97% formamide, 10 mM Tris, 10 mM EDTA, 0.05% SDS), heated to 98 °C for 2 min, snap cooled 1110 
on ice, and 8 µl were loaded onto a 12% Urea-TBE denaturing PAGE gel (Sequa-gel system, National 
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Diagnostics, Atlanta GA) prepared with 0.5x TBE. Samples were run at 50 W (approx.. 2500 V) with 0.5x 
TBE running buffer on a vertical sequencing gel apparatus (Ellard Instrumentation, Monroe WA). 
Sequencing ladders showing the positions of C or G bases in the template sequence were generated in 
10 µl reactions containing 1x Thermopol reaction buffer (NEB), 1 µl Therminator polymerase (NEB), 250 
µM dNTPs (TaKaRa), 25 µM ddGTP or ddCTP (TriLink Biotechnologies, San Diego CA), 100 nM template 
DNA (same as used in FeBABE cleavage or KMnO4 footprinting assays), 1 µM Cy3 or Cy5 labeled primer 
(same as used for primer extension), and 2 M betaine. Reactions were incubated at 95 °C for 3 min, then 
5 cycles of 95 °C for 30 seconds, 50 °C for 1 min, 72 °C for 1 min, followed by a final incubation at 72 °C 
for 3 min. Sequencing reactions were mixed with 30 µl formamide loading buffer and heated and cooled 1120 
before loading as described for the samples. Sample lanes did not include loading dye, which is 
fluorescent in both Cy3 and Cy5 channels, but empty lanes were run with formamide loading buffer 
containing both Bromophenol Blue and Xylene cyanol FF.  Following electrophoresis, gels were scanned 
directly using the fluorescence mode of a Typhoon Trio variable mode imaging system (GE Healthcare 
Life Sciences), using a PMT setting of 600 and each pixel representing 200 µm. Image analysis was 
carried out using the FIJI analysis suite (Schindelin et al., 2012). Images were background subtracted and 
contrast-adjusted and all major bands of interest in each lane were quantified. For KMnO4 footprinting, 
the intensities of the footprint bands were normalized to the intensity of the band corresponding to the 
full-length primer extension product for comparison across multiple gels. For the FeBABE cleavage, the 
intensities of each band in the lanes containing N-Fe or C-Fe SutA were normalized by dividing by the 1130 
intensities of the corresponding bands in the negative control lanes containing WT SutA.  
Data visualization 
Unless otherwise noted, molecular structures were visualized using the Chimera suite (Pettersen et al., 
2004). Graphs were produced using the ggplot2 library in R (Wickham, 2016). Gel images were 
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background-subtracted and contrast adjusted using the FIJI suite (Schindelin et al., 2012). NMR spectra 
were visualized using the CcpNmr Analysis suite (Vranken et al., 2005). LC-MS/MS spectra for cross-
linked peptides were shown using StavroX software (Götze et al., 2012). Figures were assembled using 
Adobe Acrobat CC2018.  
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Figure 1. NMR data confirm presence of alpha helix from aa 56-76 and flexible N- and C-terminal tails. A. Primary amino acid sequence for 
SutA, with computational predictions indicated: underlining = intrinsic disorder; boxing = α-helix; gray shading = β-strand. B. Schematic of constructs 
used; wavy line = α-helix region; blue = C-tail; orange = N-tail. Schematics are aligned with residue numbers and NMR data in (C). C. Secondary 
chemical shift indices, residual dipolar coupling values, transverse relaxation rates, and peaks present in the positive amide NOE spectra following 
assignment of most backbone resonances for the full-length SutA. Secondary shifts were calculated using TALOS as part of the PINE automated 
assignment server. RDCs were measured by manual comparison of in-phase-anti-phase spectra between stretched gel and aqueous solution condi-
tions. R2 values were calculated by fitting single exponential decay curves to peak integrals from spectra with increasing T2 delays. Positive NOE signal 
indicates that a peak was detected in the positive (1H-15N) NOE. The box indicates the location of the α-helix. D. One of many possible SutA structures 
modelled using the Robetta fragment server to incorporate chemical shift and RDC data, and PyRosetta. On the left, residues are colored by per-resi-
due conservation score following alignment of 25 representative homologs (see materials and methods for details). On the right, residues are colored 
by chemical properties.
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Figure 1- figure supplement 1. P. aeruginosa UBCPP-PA14-centric alignment of representa-
tive SutA homologs. SutA homologs were detected by BLAST, and representatives were selected 
from multiple families in each of the four orders in which SutA could be found (Alteromonadales, 
Cellvibrionales, Oceanospirillales, and Pseudomonadales). After alignment using the MEGA6 
software suite (Tamura et al., 2013), gaps in the P. aeruginosa UBCPP-PA14 sequence were 
removed and the aligment was visualized using the Jalview2 applet(Waterhouse et al., 2009).
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Figure 1 - figure supplement 2. In vitro transcrip-
tional activity of SutA proteins prepared for NMR, 
compared to the same proteins prepared using 
standard methods. Activity of proteins produced for 
NMR was tested using the single-turnover initiation 
assay with EσS as described for Figure 2.
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Figure 1 - figure supplement 3. 1H-15N 
HSQC spectra comparing the 
full-length WT SutA to ∆N and ∆C 
proteins. 1H-15NHSQC spectra for SutA∆
C (top) and SutA∆N (bottom) (both in 
magenta) were overlaid on the  1H-15N 
HSQC for the full-length SutA 
(turquoise). Apart from the loss of the 
truncated residues, only a few peaks 
near the newly created C- or N-terminus 
are perturbed. 
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Figure 1 - figure supplement 4. A selection of low-resolution SutA decoys generated by PyRosetta modeling 
utilizing NMR chemical shift and RDC data. The model used for Figure 1D is in the second row, first column. SutA is a 
very flexible protein, with its only secondary structural feature being an α-helix encompassing residues 56-76, and even that 
helix displays some predicted possible flexibility. We did not detect a peak for the Gln61 residue, the point in the helix that 
shows the most variation in these models.
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Figure 2. Effects of SutA variants on transcription initiation. A. Promoter sequences. -10 and -35 motifs are indicated in bold 
and boxed (no consensus -35 motif has been defined for σS in P. aeruginosa), transcription start sites are indicated by circles, 
and the discriminator region is noted (Disc.). B. Representative gel images for single-turnover reactions containing 20 nM RNAP 
holoenzyme, 15 nM linear template, 20 µg/ml heparin, 75 µM initiating dinucleotide, 50 µM NTPs for the bases not labeled in the 
experiment, 20 µM cold NTP for the base carrying the 32P label, and 0.75 µCi α32P labeled GTP or CTP per 5 µl reaction, in TGA 
buffer. Reactions were quenched and loaded onto 20% denaturing polyacrylamide gels. Both bands are productive transcripts 
that arise from termination near the end of the linear template. Contrast was adjusted according to signal; σS activity was much 
less than σ70 activity. C. Amount of transcript produced in the presence of varying concentrations of SutA, compared to the 
amount produced in the absence of SutA, expressed as a log2-transformed ratio. Reactions were as described above, except for 
reactions including pepB promoter and σS holoenzyme, which contained 40 nM RNAP. Individual replicate values are plotted (n≥
3), and lines connect the average of all replicates at each concentration. D. SutA effects in vivo. WT, ∆N, or ∆C SutA were 
expressed from an arabinose-inducible promoter in a ∆sutA strain or ∆sutA ∆rpoS strain (WT SutA only, “∆S”). Strains were 
grown overnight in LB and diluted 1:1000 into minimal medium containing 40 mM pyruvate as a carbon source ± 20 mM arabi-
nose. After 24 hours, during which cultures slowly reached stationary phase, transcript levels were measured by qRT-PCR. Each 
transcript of interest was normalized to the number of oprI transcripts in the same sample. Symbols represent average values for 
triplicate measurements, and lines represent the range of values.
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Figure 2 - figure supplement 1. Induction of SutA overexpression in E. 
coli does not cause upregulation of rrn expression. SutA under control of 
an arabinose-inducible promoter on the pMQ72 plasmid backbone, or the 
empty vector, was introduced into either E. coli MG1655 or P. aeruginosa 
UBCPP-PA14 ∆sutA, and cells were grown into late stationary phase in LB in 
the presence of 20 mM arabinose before harvesting them, extracting RNA, 
and measuring nascent rrn transcript levels by qRT-PCR. Symbols represent 
the average value from 3 biological replicates, and vertical lines represent the 
range of values observed.
Figure 2 - figure supplement 2. 5’RACE to determine the transcrip-
tion start site for rrn in P. aeruginosa. Total RNA was extracted from 
P. aeruginosa UCBPP-PA14 in exponential, early stationary, or late 
stationary phase, and the leader sequence of the rrn transcript was 
reverse transcribed, T-tailed, PCR-amplified, and cloned into pUC18. 
Several clones from the stationary phase time points were from 
transcripts whose 5’ ends corresponded to the RNase III cleavage site 
in the rrn leader, based on comparison to the E. coli sequence, but 
clones whose 5’ ends corresponded to putative transcription start sites 
were distributed as shown.
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Figure 2 - figure supplement 3. Full length gels for one replicate of each promoter/holoenzyme/SutA combination 
shown in Figure 2. The rrn/EσS/31 nM SutA ∆C sample was degraded, and an additional replicate of this sample was run on 
a subsequent gel. 
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Figure 3. Crosslinking and affinity cleavage suggest that SutA binds to the β subunit of RNAP. A. Contacts with the β1 domain. P. aeruginosa 
sequence was threaded onto a structural model of the E. coli β (PDB ID: 5UAG) for interpretation of cross-linking results. A topology diagram of the 
contacts inferred by cross-linking (BS3, green lines; BPA, orange lines) and FeBABE-mediated cleavage (blue lines). The contact residues on β1 are 
colored accordingly. Crosslinked residues were identified by LC-MS/MS, cleavage sites were determined by SDS-PAGE and Western blotting of the 
cleaved complexes, using a large-format gel system and an antibody raised against a peptide at the extreme C-terminus of the E. coli β. See text, 
supplemental figures, and materials and methods for further details. B. Contacts around the βi9 and β flap domains. Distances from the β1 cross-
links suggest this may be a secondary, weaker site. C. Cryo-EM structure of E. coli Eσ70 (PDB: 6CA0), indicating relative positions of β1 (darker 
blue, same as region shown in (A), and fragment purified for (D)) and βi9/β flap regions (pink, same as region shown in (B)). D. 1H-15N HSQC 
spectra showing that chemical shifts for a handful of residues are perturbed when 15N-labeled SutA is mixed with unlabeled β1 domain (pink) vs 
unlabeled σS (turquoise). A small number of extra peaks show up only in the σS mixture (turquoise, lower right quadrant); these are most likely due to 
very low levels of protein cleavage in the C-terminal disordered tail of SutA caused by a minor protease contaminant present in the σS protein 
preparation which occurred during an extended period of exposure to ambient temperatures. 
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Figure 3 - figure supplement 1.BS3 crosslinking visualization and analysis. A Coomassie-stained SDS-PAGE gel showing BS3 
cross-linking of RNAP-SutA complexes, a comparison of the score differences calculated for intra-RNAP cross-links versus 
the distances between the cross-links in a published RNAP structure that was used to determine an appropriate score differ-
ence cut-off for likely real cross-links, and a list of SutA-RNAP cross-links, the number of spectra in which they were detected, 
and the maximum score difference observed.
Figure 3 - figure supplement 2. A Coomassie stained SDS-PAGE gel and a Western blot using an anti-β antibody showing the 
formation of shifted β bands following SutA BPA variant crosslinking to β.   
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Figure 3 Supplement 3. LC-MS/MS spectra from crosslinked peptides detected in the BS3 experiment. Output from StavroX analysis software 
shows multiple detected fragment ions from both component peptides, indicating high-quality identifications of crosslinked peptides.
.CC-BY-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/423384doi: bioRxiv preprint first posted online Sep. 20, 2018; 
1+
1+
1+
1+
2+
2+
2+
2+
3+
3+
3+
3+
[RAVKE]
[AKQKE]
m/z
200.0
200.0
300.0
300.0
400.0
400.0
500.0
500.0
600.0
600.0
700.0
700.0
800.0
800.0
900.0
900.0
1000.0
1000.0
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
110.0
0.0
25.0
-25.0
50.0
-50.0
344.241+
602.3611+
y1β
1+
y1
1+
148.06
b4β
2+
b4
2+
598.36
129.102
740.431+b3β
1+
327.213
301.6832+
412.2562+
563.3152+
b2
1+
200.139
299.218
338.7292+
584.359
576.8382+
455.308
562.843
868.523y4
2+
636.367
y2β
1+
1016.555
997.571
0% rel. intensity 100%
re
la
tiv
e 
in
te
ns
ity
 [%
]
de
vi
at
io
n 
[p
pm
]
SutA 62 - β 481 crosslink
SutA 59-63 
(α peptide):
β 478-482
(β peptide): 
1+
1+
1+
1+
[FLQAGATKE]
[RDALAKAMEE]
0% rel. intensity 100%
m/z
200.0
200.0
300.0
300.0
400.0
400.0
500.0
500.0
600.0
600.0
700.0
700.0
800.0
800.0
900.0
900.0
1000.0
1000.0
1100.0
1100.0
1200.0
1200.0
1300.0
1300.0
1400.0
1400.0
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
110.0
120.0
0.0
25.0
-25.0
50.0
-50.0
y2  (-18)
1+
259.091
b3β
1+
389.218
b5
1+
527.296 544.319
233.165
261.091
b4β
1+
460.254
y2
1+
277.103
y3
1+
408.147
1368.747
1440.825
re
la
tiv
e 
in
te
ns
ity
 [%
]
de
vi
at
io
n 
[p
pm
]
SutA 69 - β 45 crosslink
SutA 64-73 
(α peptide):
β 38-46
(β peptide): 
α
α
α
α
α
α
α
α
.CC-BY-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/423384doi: bioRxiv preprint first posted online Sep. 20, 2018; 
m/z
100.0
100.0
200.0
200.0
300.0
300.0
400.0
400.0
500.0
500.0
600.0
600.0
700.0
700.0
800.0
800.0
900.0
900.0
1000.0
1000.0
1100.0
1100.0
1200.0
1200.0
1300.0
1300.0
1400.0
1400.0
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
110.0
120.0
0.0
5.0
-5.0
122.081
y6ɑ
1+
630.345
748.45
171.149
115.087
b2ɑ
1+
143.081
y2ɑ
1+
218.15
749.453
229.118
y1ɑ(-18)
1+
129.102
631.348
413.203
703.395
y4β
1+
444.293
897.46
905.487508.764
374.728
767.916
1034.529 1163.57
632.351
1+
1+
1+
1+
2+
2+
2+
2+
[VGLVR]
[AAVVEEExPSVEAK]
0% rel. intensity 100%
SutA L54BPA
47-60
(α peptide):
β 471-475
(β peptide):
m/z
200.0
200.0
400.0
400.0
600.0
600.0
800.0
800.0
1000.0
1000.0
1200.0
1200.0
1400.0
1400.0
1600.0
1600.0
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
110.0
120.0
0.0
5.0
-5.0
y3β
1+
341.218
775.461
y9β
1+
936.515y7ɑ
1+
669.43b2β
1+
228.134 596.305 937.517
y1β
1+
y1ɑ
1+
147.113
y10ɑ
1+
982.602 1236.581
y6β
1+
626.35
117.103
304.2
y15ɑ
1+
1548.908
1+
1+
1+
1+
2+
2+
2+
2+
[VQExEPNVVADPPK]
[ERLSmAESEGLMPQDLINAKPVAAAIK]ɑ
0% rel. intensity 100%
SutA I84BPA
81-94
(β peptide):
β 482-508
(α peptide):
SutA BPA54-β 471 crosslink
SutA BPA84-β 493 crosslink
re
la
tiv
e 
in
te
ns
ity
 [%
]
de
vi
at
io
n 
[p
pm
]
re
la
tiv
e 
in
te
ns
ity
 [%
]
de
vi
at
io
n 
[p
pm
]
Figure 3 Supple-
ment 4. LC-MS/MS 
spectra from 
crosslinked 
peptides detected 
in the BPA experi-
ments. Output from 
StavroX analysis 
software shows 
multiple detected 
fragment ions from 
both component 
peptides, indicating 
high-quality 
identifications of 
crosslinked 
peptides.
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Figure 3 - figure supplement 5. 16x16 cm Western blots from two different percentages of acrylamide, for calculation of 
FeBABE cleavage positions. Western blotting of FeBABE cleavage products was performed in a large format to allow for accurate 
calculation of the molecular weights of the cleavage products. For each known fragment, generated by overexpressing a cloned 
fragment of P. aeruginosa β in E. coli, the molecular weight was calculated using the ExPASy Compute pI/Mw tool, and the log of 
this value was plotted against the ratio: (distance traveled by band/distance traveled by dye front). The linear relationship estab-
lished was used to calculate the molecular weights of the FeBABE cleavage products based on their band/dye front ratios, and 
those molecular weights were used to determine the amino acid position at which the cleavage occurred.
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Figure 4. Both σ factor and DNA compete with SutA for binding to the core RNAP. A. Models based on E. coli σ70 and σS holoenzyme 
structures show potential interactions between σ factors and SutA. The inset shows the perspective and extent of this view relative to the holoen-
zyme structure shown in (3C). The P. aeruginosa β sequence was threaded onto an E. coli crystal structure (PBD: 5UAG), and then the β subunit 
from this was docked into the Eσ70 cryoEM structure (top) (PDB:6CA0) or the EσS crystal structure (bottom) (PDB:5IPN). Residues showing 
crosslink or cleavage reactivity with SutA (Fig. 3) are colored magenta. Residues 168-212 of σ70, which are not visualized in the cryoEM structure, 
were modelled in as a flexible loop. Two different possible positions are shown (red and dark blue), one of which (red) could clearly clash with both 
the DNA and SutA positions (top). In contrast, σS does not appear likely to directly contact SutA (bottom). B. Sequence and structure of template 
DNA surrounding transcription start site. C. Western blot showing cross-linking of a SutA variant in which L54 has been replaced by BPA to β, in the 
context of different σ factors and promoter DNA. Reactions contained 100 nM RNAP, 100 nM DNA, 100 mM NaCl, and the indicated amounts of 
L54BPA SutA in TGA buffer. “∆AL” refers to a mutant of σ70 lacking amino acids 171-214 (P. aeruginosa sequence). D. Western blots showing β 
cleavage mediated by N-Fe or C-Fe SutA FeBABE conjugates. Reactions components besides SutA variant were the same as in (C). Sizes of 
cleavage products were estimated by comparison to β fragments of known sizes analyzed on large non-gradient gels (see supplements to figures 3 
and 4); for some products (~), only approximate sizes can be determined. The blot for C-Fe was exposed for longer (4 minutes) than the blot for 
N-Fe (30 seconds). 
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Figure 4 - figure supplement 1. Longer exposure of 
Western blot showing crosslinking of 2 µM L54BPA 
SutA to β. A low level of crosslinking is detectable in the 
presence of Eσ70 and the rrn bubble template, but no 
crosslinking is detected in the presence of E. coli Eσ70, 
even in the absence of DNA.
Figure 4 - figure supplement 2. Western blot showing 
FeBABE cleavage experimental controls.  β fragment 
standards used to determine cleavage positions were 
run on the mini-gel format for direct comparison to 
cleavage products observed in open complex contexts, 
and E. coli Eσ70 FeBABE cleavage experiments were 
also run and showed no detectable cleavage.
Figure 4 - figure supplement 3. In vitro transcription 
experiments using Eσ70∆AL, with the transcription 
level of the Eσ70 holoenzyme in the absence of SutA 
shown for comparison. Single-turnover initiation 
assays were performed as described in Figure 2. Eσ70∆
AL appears to have a mild transcription initiation defect, 
and causes SutA to have more muted effects on 
initiation.
.CC-BY-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/423384doi: bioRxiv preprint first posted online Sep. 20, 2018; 
no
 p
ro
te
in
C    G 0 .25 2 0 .25 2 0 .25 2
∆NWT ∆CWT WT ∆NWT ∆C WTWT SutA 
µM
Sigma
A.
0 .25 2 0 .25 2 0 .25 2
none
WT .25 µM
∆N 
∆C 
500
1500
1000
2000
si
gn
al
 in
te
ns
ity
T -12
T -9
T -10
C -11
[SutA] (µM):
-12 -8 -4
-1
+4
-12
-8
-1
+4
-12 -8 -4
-1
+4
-12
-8
-1
+4
0 2.5
C Fe
N Fe
-12 -8 -4
-1
+4
-12
-8
-1
+4
-12 -8 -4
-1
+4
-12
-8
-1
+4
B.
Fold increase 
over background
WT 2 µM
-11
σ70 σS 
σ70 
σ70 
σS 
σS 
σ70 ∆AL  
σ70 ∆AL  Sigma:
Figure 5. SutA enhances RNAP-DNA interaction, and its tails access the transcription bubble DNA. A. Representative potassium permanga-
nate (KMnO4) footprinting experiment followed by primer extension shows the effects of WT, ∆N, or ∆C SutA on the amount of OC formed upon 
interaction between the rrn DNA and the holoenzyme. Reactions contained 100 nM RNAP holoenzyme, 15 nM template DNA, and the indicated 
amounts of SutA. The template strand was probed using a Cy5-labeled primer. B. Signal intensity from triplicate measurements of the “TTCT” 
bands (-9 through -12), normalized to the total intensity in each lane (dominated by uncut DNA extension product; see supplement), is shown 
(right). Error bars are standard error of the mean. P-values for significant differences, as calculated by one-way ANOVA and Tukey’s HSD, are 
indicated by asterisks: *≤ 0.05, **≤ 0.01, ***≤ 0.001. C. Cleavage of the DNA in the rrn OCs formed by Eσ70 or EσS in the presence of N-Fe or C-Fe 
SutA, revealed by primer extension. Average log2-transformed enrichment in signal between the FeBABE reaction and a negative control reaction 
containing unmodified SutA, from triplicate measurements, is represented by color intensity for each base.
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Figure 5 - figure supplement 1. Full length representative gel for one replicate of KMnO4 footprinting assay.
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Figure 5 - figure supplement 2. Full length gels for triplicate measurements of FeBABE DNA cleavage for rrn promoter with EσS and 
Eσ70. Regions represented by color scales in Figure 5C are outlined with red boxes. Images were contrast-adjusted to make signal more 
visible; cleavage was much stronger for EσS.
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Figure 6. Regulation of the rrn OC formed by Eσ70 holoenzyme. A. DksA and ppGpp repress initiation from the rrn promoter, and SutA does 
not overcome these effects. Single turnover initiation reactions were performed using 500 nM SutA and/or 250 nM DksA and 2.5 µM ppGpp as 
indicated with 20 nM Eσ70, 15 nM promoter DNA, and 20 µg/ml heparin. RNAs were run on a 20% denaturing polyacrylamide gel and visualized 
by phosphorimaging. Symbols indicate the average value for the three replicates and lines represent the range of values. B. SutA effects in the 
presence of different concentrations of iNTPs, CTP and UTP, the first two nucleotides of the rrn transcript. Symbols reflect the average signal 
intensity (normalized such that the average signal for the 0 nM SutA condition for a given [iNTP] was the same across different gels) and lines 
represent the range of values observed in replicate experiments (n=3). C. The heparin-resistant rrn OC is short-lived and its lifetime is not 
affected by SutA. The OC was formed with 20 nM Eσ70 (black) or EσS (red) and 15 nM promoter DNA and challenged with heparin. NTPs were 
added at the indicated times and transcription was allowed to proceed for 8 minutes before quenching the reaction and running on a 20% gel. 
Reactions were performed at least in duplicate. D. SutA effects are reduced on an artificial transcription bubble. Multiple turnover assays were 
performed using 15 nM template, 20 nM holoenzyme, and either 500 nM SutA or an equivalent volume of storage buffer. To normalize values 
across different gels for comparison to single turnover assays on dsDNA template, the median value for the Eσ70 reactions with no SutA present 
on each gel was set to the same level, and other values from that gel adjusted accordingly. Symbols represent the average values for at least 5 
replicate bubble transcript reactions, and vertical lines represent the range of values observed. Horizontal lines show values from the experiments 
on the dsDNA template shown in Figure 2, normalized in the same way as the bubble template data for comparison. 
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Figure 6 - figure supplement 1. Gel for DksA experiment. 
Experiment described in main figure legend.
Figure 6 - figure supplement 2. Gel for DksA experiment. 
Experiment described in main figure legend.
Figure 6 - figure supplement 3. Gel for DksA experiment. 
Experiment described in main figure legend.
Figure 6 - figure supplement 4. Gel for DksA experiment. 
Experiment described in main figure legend.
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Figure 7. SutA destabilizes RNAP-DNA interactions on the bcn promoter. A. The heparin-resistant Eσ70-bcn OC is long-lived and its lifetime is 
not affected by SutA. The OC was formed with 20 nM Eσ70 and 15 nM promoter DNA and challenged with heparin. NTPs were added at the 
indicated times and transcription was allowed to proceed for 8 minutes before quenching the reaction and running on a 20% gel. Reactions were 
performed at least in duplicate. B. SutA interacts only weakly with Eσ70-bcn OC, and AL deletion slightly increases the interaction of the C-tail with 
RNAP. Cross-linking with the L54BPA or cleavage with Fe-conjugated SutA variants were performed as described in Figure 4. C. Representative 
KMnO4 footprinting reactions with either WT or ∆AL σ70 holoenzyme. The non-template strand (with a -10 motif sequence of 5’ TAATTTT) was 
probed by primer extension. D. Quantification of -6 to -9 footprint signal from experiments performed at least in triplicate. Error bars represent 
standard error of the mean. P-values for intuitive comparisons that are significantly different, calculated by one-way anova and Tukey’s HSD, are 
indicated by asterisks: *≤ 0.05, **≤0.01, ***≤ 0.001.
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Figure 7 - figure supplement 1. Representative 
gel for open complex stability assay. Experi-
ment described in main figure legend.
Figure 7 - figure supplement 2. Representative 
full length gel for one replicate of KMnO4 
footprinting assay.
Figure 7 - figure supplement 3. FeBABE DNA 
cleavage for bcn promoter with Eσ70. Experi-
ment was carried out as described for rrn promoter 
in Figure 5. No detectable cleavage was observed. 
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Figure 8.  Model of interactions between SutA and RNAP in the context of different promoters and holoenzymes. With EσS and rrn 
(left), the C-terminus of SutA interacts robustly with β1 and also is in close proximity to the upstream portion of the transcription bubble, and 
contributes to stabilizing these interactions. The N-terminus of SutA interacts with β near the cleft between the β1 and β2 domains, and also 
with the non-template strand in the vicinity of the transcription start site. With Eσ70 and rrn (center), the interaction between the C-terminus of 
SutA and β is inhibited by the σ70AL, and the position of the C-terminus relative to the transcription bubble changes, but the N-terminus of SutA 
can still interact robustly near the β1/β2 cleft and with the non-template strand. With Eσ70 and bcn, the presence of SutA blocks open complex 
formation, and the presence of the bcn promoter destabilizes the interaction between SutA and β1 (right).
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Table 1: SutA Backbone chemical shift values (ppm)
Residue number C CA CB HA N HN
Met 1 176.33 55.92 32.94 ND ND ND
Ser 2 174.77 58.50 63.86 4.48 117.49 8.60
Glu 3 176.79 57.36 29.98 4.22 122.48 8.63
Glu 4 ND 56.79 30.12 4.25 121.69 8.31
Glu 5 176.49 ND ND ND ND ND
Leu 6 ND 55.06 42.34 ND 124.68 8.44
Glu 7 176.49 56.41 30.00 ND 121.66 8.43
Gln 8 ND ND ND ND ND ND
Asp 9 ND ND ND ND ND ND
Glu 10 ND ND ND ND ND ND
Leu 11 176.65 56.62 30.05 ND ND ND
Asp 12 177.03 55.19 42.18 4.56 123.29 8.40
Gly 13 174.06 45.35 ND 3.86 109.45 8.50
Ala 14 177.61 52.45 19.44 4.80 123.87 8.20
Asp 15 176.36 54.28 41.03 4.56 120.20 8.48
Glu 16 175.75 55.69 29.67 4.24 121.24 8.43
Asp 17 ND 54.63 41.24 4.59 122.29 8.53
Asp 18 ND ND ND ND 122.29 8.53
Gly 19 ND 45.38 ND ND 109.38 8.49
Glu 20 ND 56.39 30.29 4.24 120.70 8.33
Glu 21 ND ND ND 4.24 122.88 8.61
Leu 22 177.18 54.97 42.36 4.18 123.21 8.27
Ala 23 ND 52.25 19.19 4.25 125.88 8.40
Ala 24 ND ND ND ND ND ND
Ala 25 ND 52.45 19.28 ND ND ND
Asp 26 ND 54.05 41.16 4.59 120.28 8.48
Asp 27 176.85 54.37 41.09 4.56 121.69 8.39
Gly 28 ND 45.39 ND ND 109.95 8.42
Glu 29 176.53 56.26 30.16 ND ND ND
Ala 30 177.54 52.43 19.25 4.25 125.43 8.45
Asp 31 176.47 54.10 41.24 4.56 120.31 8.42
Ser 32 174.86 58.27 63.82 4.43 117.23 8.42
Ser 33 174.51 58.59 63.87 4.48 118.51 8.59
Asp 34 176.76 54.53 40.99 4.25 122.61 8.47
Gly 35 174.40 45.40 ND 3.86 109.45 8.38
Asp 36 ND 54.41 41.17 ND 120.74 8.32
Glu 37 176.00 56.19 30.11 4.32 ND ND
Ala 38 ND 50.51 17.95 4.55 127.00 8.42
Pro 39 176.39 63.49 31.88 ND ND ND
Ala 40 ND 50.46 18.05 ND 125.96 8.51
Pro 41 177.79 ND ND ND ND ND
Gly 42 ND ND ND 3.62 109.42 8.58
Lys 43 176.72 ND ND 4.24 ND ND
Lys 44 176.30 56.16 32.95 4.53 123.32 8.45
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Ala 45 ND 52.28 19.22 ND 126.21 8.42
Lys 46 176.35 56.07 33.01 4.07 124.22 8.56
Ala 47 177.29 52.36 19.23 ND 126.23 8.46
Ala 48 177.67 52.27 19.11 ND 124.41 8.46
Val 49 177.67 62.24 32.81 ND 120.94 8.28
Val 50 176.04 62.06 32.73 4.08 125.85 8.45
Glu 51 176.17 56.46 30.50 4.08 126.07 8.64
Glu 52 ND 56.39 ND 4.32 122.72 8.55
Glu 53 176.20 56.22 30.48 4.53 123.05 8.56
Leu 54 ND 53.62 41.47 ND 125.63 8.54
Pro 55 177.14 63.23 32.06 ND ND ND
Ser 56 175.28 58.39 63.97 ND 116.74 8.44
Val 57 ND 64.43 32.23 ND 122.36 8.38
Glu 58 177.98 58.44 29.51 ND 122.67 8.52
Ala 59 180.86 54.56 18.45 4.25 124.27 8.35
Lys 60 ND 57.55 33.44 ND 121.16 8.14
Gln 61 ND ND ND ND ND ND
Lys 62 178.52 57.55 36.17 4.07 120.19 8.26
Glu 63 177.73 ND ND ND 120.71 8.03
Arg 64 179.25 59.22 30.12 ND 120.51 8.12
Asp 65 178.26 56.67 40.04 4.32 121.46 8.68
Ala 66 180.75 54.98 17.93 4.18 123.80 8.15
Leu 67 179.26 57.44 41.56 ND 119.14 8.21
Ala 68 ND 54.96 17.89 4.18 122.71 8.06
Lys 69 ND 58.67 32.21 4.14 119.95 8.11
Ala 70 ND 54.66 17.95 4.25 122.00 8.01
Met 71 ND ND ND 4.22 119.21 8.30
Glu 72 178.49 58.91 28.29 4.07 120.16 8.28
Glu 73 178.49 58.80 29.30 3.99 120.20 8.23
Phe 74 178.21 60.60 39.18 ND 121.04 8.20
Leu 75 179.73 56.90 41.63 4.02 120.03 8.43
Ser 76 175.43 60.27 63.26 4.32 115.72 8.18
Arg 77 176.94 56.69 30.26 4.32 120.72 7.72
Gly 78 174.73 45.34 ND 3.46 108.39 8.06
Gly 79 173.34 45.18 ND ND 108.55 8.06
Lys 80 176.52 55.61 33.58 4.40 120.98 8.08
Val 81 175.95 62.58 33.02 ND 122.89 8.43
Gln 82 175.70 55.63 29.56 4.40 124.81 8.60
Glu 83 176.16 56.40 30.33 4.24 123.71 8.60
Ile 84 176.05 60.87 38.75 4.11 122.60 8.34
Glu 85 ND 54.24 29.77 4.59 127.40 8.61
Pro 86 176.54 63.06 32.17 ND ND ND
Asn 87 174.99 53.25 38.74 4.66 119.10 8.64
Val 88 176.01 62.31 32.84 4.08 121.53 8.18
Val 89 175.67 62.12 32.55 4.08 125.63 8.37
Ala 90 177.08 52.20 19.44 4.25 128.97 8.48
Asp 91 ND 52.56 40.22 4.25 121.53 8.42
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Pro 92 ND ND ND ND ND ND
Pro 93 176.82 62.75 31.95 ND ND ND
Lys 94 176.57 55.93 33.12 4.40 122.12 8.50
Lys 95 ND 54.29 ND 4.59 124.86 8.56
Pro 96 176.59 63.16 31.97 ND ND ND
Asp 97 176.68 54.22 41.11 4.56 121.26 8.56
Ser 98 176.68 58.66 63.74 4.36 117.22 8.42
Lys 99 176.67 56.85 32.54 4.02 123.24 8.49
Tyr 100 176.56 58.22 38.51 4.53 120.61 8.22
Gly 101 174.06 45.21 ND 3.62 110.87 8.30
Ser 102 174.15 58.28 63.87 4.48 115.84 8.24
Arg 103 ND 54.04 30.23 ND 124.12 8.39
Pro 104 176.07 63.34 31.80 ND ND ND
Ile 105 181.35 63.20 39.46 ND 125.54 7.87
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Table 2: Strains
Strains for in vivo  experiments:
strain Strain background genotype source
DKN263 P. aeruginosa UCBPP-PA14
DKN1625 P. aeruginosa UCBPP-PA14 ∆sutA Babin et al. 2016
DKN1871  P. aeruginosa UCBPP-PA14 ∆sutA  attTn7:: P BAD :sutA Gm
R
This study
DKN1872  P. aeruginosa UCBPP-PA14 ∆sutA  attTn7:: P BAD :sutA ∆N Gm
R
This study
DKN1873  P. aeruginosa UCBPP-PA14 ∆sutA  attTn7:: P BAD :sutA ∆C Gm
R
This study
DKN1874  P. aeruginosa UCBPP-PA14 ∆sutA∆rpoS This study
DKN1875  P. aeruginosa UCBPP-PA14 ∆sutA∆rpoS  attTn7:: P BAD :sutA Gm
R
A gift from Doug Lies, originally from the laboratory of Carol Gross
DKN81 E. coli MG1655 (F− λ− rph-1)
E. coli strains for cloning and protein expression:
strain plasmid description Strain background genotype Choi and Schweizer 2006
DKN1298 pTNS1 SM10 Choi and Schweizer 2006
DKN1299 pRK2013 HB101 (F− λ− Δ(gpt-proA)62 leuB6 glnV44(AS) araC14 galK2(Oc) lacY1 Δ(mcrC-mrr) rpsL20(StrR) xylA5 mtl-1 recA13 hsdS20) Babin et al. 2016
DKN1637 pMQ30_sutA DH5α (F
- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZ ΔM15 Δ(lacZYA-argF )U169, hsdR17(rK
- mK
+), λ–) Shanks et al . 2006 
DKN548 pMQ72 F− Δ(argF-lac)169 Φ80dlacZ58(ΔM15) glnV44(AS) λ− rfbC1 gyrA96(NalR) recA1 endA1 spoT1 thi-1 hsdR17 deoR Babin et al. 2016
DKN1640 pMQ72_HASutA Mach1 (ΔrecA1398 endA1 tonA Φ80ΔlacZM15 ΔlacX74 hsdR(rK
- mK
+) ) Babin et al. 2016
DKN1639 pUC18T-mini-Tn7T-GmR PBAD :sutA Mach1 (ΔrecA1398 endA1 tonA Φ80ΔlacZM15 ΔlacX74 hsdR(rK
- mK
+) )
DKN1876 pUC18T-mini-Tn7T-Gm
R PBAD :sutA∆N DH10β (F
- endA1 recA1 galE15 galK16 nupG rpsL ΔlacX74 Φ80lacZΔM15 araD139 Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC), λ - )
DKN1877 pUC18T-mini-Tn7T-Gm
R PBAD :sutA∆C DH10β (F
- endA1 recA1 galE15 galK16 nupG rpsL ΔlacX74 Φ80lacZΔM15 araD139 Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC), λ - ) This study
DKN1697 pQE-80L SutA BL21 DE3 (F
– ompT gal dcm lon hsdSB(rB
- mB
-) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5]))
DKN1878 pQE-80L SutA 46-101 BL21 DE3 (F
– ompT gal dcm lon hsdSB(rB
- mB
-) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])) This study
DKN1879 pQE-80L SutA∆N BL21 DE3 (F
– ompT gal dcm lon hsdSB(rB
- mB
-) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])) This study
DKN1880 pQE-80L SutA∆C BL21 DE3 (F
– ompT gal dcm lon hsdSB(rB
- mB
-) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])) This study
DKN1881 pQE-80L SutA 6amber Mach1 (ΔrecA1398 endA1 tonA Φ80ΔlacZM15 ΔlacX74 hsdR(rK
- mK
+) ) This study
DKN1882 pQE-80L SutA 11amber Mach1 (ΔrecA1398 endA1 tonA Φ80ΔlacZM15 ΔlacX74 hsdR(rK
- mK
+) ) This study
DKN1883 pQE-80L SutA 22amber Mach1 (ΔrecA1398 endA1 tonA Φ80ΔlacZM15 ΔlacX74 hsdR(rK
- mK
+) ) This study
DKN1884 pQE-80L SutA 54amber Mach1 (ΔrecA1398 endA1 tonA Φ80ΔlacZM15 ΔlacX74 hsdR(rK
- mK
+) ) This study
DKN1885 pQE-80L SutA 61amber Mach1 (ΔrecA1398 endA1 tonA Φ80ΔlacZM15 ΔlacX74 hsdR(rK
- mK
+) ) This study
DKN1886 pQE-80L SutA 74amber Mach1 (ΔrecA1398 endA1 tonA Φ80ΔlacZM15 ΔlacX74 hsdR(rK
- mK
+) ) This study
DKN1887 pQE-80L SutA 84amber Mach1 (ΔrecA1398 endA1 tonA Φ80ΔlacZM15 ΔlacX74 hsdR(rK
- mK
+) ) This study
DKN1888 pQE-80L SutA 89amber Mach1 (ΔrecA1398 endA1 tonA Φ80ΔlacZM15 ΔlacX74 hsdR(rK
- mK
+) ) This study
DKN1889 pQE-80L SutA 100amber Mach1 (ΔrecA1398 endA1 tonA Φ80ΔlacZM15 ΔlacX74 hsdR(rK
- mK
+) ) This study
DKN1890 pQE-80L SutA S2C DH10β (F
- endA1 recA1 galE15 galK16 nupG rpsL ΔlacX74 Φ80lacZΔM15 araD139 Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC), λ - ) This study
DKN1891 pQE-80L SutA S32C DH10β (F
- endA1 recA1 galE15 galK16 nupG rpsL ΔlacX74 Φ80lacZΔM15 araD139 Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC), λ - ) This study
DKN1892 pQE-80L SutA S98C DH10β (F
- endA1 recA1 galE15 galK16 nupG rpsL ΔlacX74 Φ80lacZΔM15 araD139 Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC), λ - ) This study
DKN1893 pQE-80L DksA BL21 DE3 (F
– ompT gal dcm lon hsdSB(rB
- mB
-) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])) This study
DKN1894 pET15b RpoS BL21 DE3 (F
– ompT gal dcm lon hsdSB(rB
- mB
-) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])) This study
DKN1895 pQE-80L RpoB B1 E. coli B F
– ompT hsdS(rB
–mB
–) dcm+ Tetr gal λ(DE3) endA Hte [cpn10 cpn60 Gentr] (Arctic Express (DE3) from Agilent) This study
DKN1896 pQE-80L RpoB355 notag DH10β (F
- endA1 recA1 galE15 galK16 nupG rpsL ΔlacX74 Φ80lacZΔM15 araD139 Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC), λ - ) This study
DKN1897 pQE-80L RpoB450 notag DH10β (F
- endA1 recA1 galE15 galK16 nupG rpsL ΔlacX74 Φ80lacZΔM15 araD139 Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC), λ - ) This study
DKN1898 pQE-80L RpoB520 notag DH10β (F
- endA1 recA1 galE15 galK16 nupG rpsL ΔlacX74 Φ80lacZΔM15 araD139 Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC), λ - ) This study
DKN1899 pQE-80L RpoB626 notag DH10β (F
- endA1 recA1 galE15 galK16 nupG rpsL ΔlacX74 Φ80lacZΔM15 araD139 Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC), λ - ) This study
DKN1900 pQE-80L RpoB1062 notag DH10β (F
- endA1 recA1 galE15 galK16 nupG rpsL ΔlacX74 Φ80lacZΔM15 araD139 Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC), λ - ) This study
DKN1901 pET15b RpoD BL21 DE3 (F
– ompT gal dcm lon hsdSB(rB
- mB
-) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])) This study
DKN1902 pET15b RpoD ∆171-214 BL21 DE3 (F
– ompT gal dcm lon hsdSB(rB
- mB
-) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])) This study
DKN1903 pUC18 rrn template DH10β (F
- endA1 recA1 galE15 galK16 nupG rpsL ΔlacX74 Φ80lacZΔM15 araD139 Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC), λ - ) This study
DKN1904 pUC18 bcn template DH10β (F
- endA1 recA1 galE15 galK16 nupG rpsL ΔlacX74 Φ80lacZΔM15 araD139 Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC), λ - ) This study
DKN1905 pUC18 pepB template DH10β (F
- endA1 recA1 galE15 galK16 nupG rpsL ΔlacX74 Φ80lacZΔM15 araD139 Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC), λ - )
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Table 3: Primers
Name Sequence Purpose
SutATEV F gagaacctgtacttccagagcATGAGCGAAGAAGAACTGGA Plasmid mutagenesis
SutATEV R GTGATGGTGATGGTGATGCG Plasmid mutagenesis
SutA46-101 gF GAACCTGTACTTCCAGAGCATGAAAGCCGCCGTGGTGGAAG Gibson cloning into plasmid
SutA46-101 gR AGCTCAGCTAATTAAGCTTTCAGCCGTACTTGCTGTCCGG Gibson cloning into plasmid
SutA46-101 pF CCGGACAGCAAGTACGGCTGAAAGCTTAATTAGCTGAGCT Gibson cloning into plasmid
SutA46-101 pR CTTCCACCACGGCGGCTTTCATGCTCTGGAAGTACAGGTTC Gibson cloning into plasmid
SutAdN F ggcaagaaggcgaaagccg Plasmid mutagenesis
SutAdN R CATgctctggaagtacaggt Plasmid mutagenesis
SutAdC F TGAAAGCTTAATTAGCTGAGCTTGG Plasmid mutagenesis
SutAdC R gttgggttcgatctcctgca Plasmid mutagenesis
SutAdN MQ72 R CATGGTCAACCcctcctgag Plasmid mutagenesis
SutAdC MQ72 F taaatcagaacgcagaagcgg Plasmid mutagenesis
SutA S2C F GCGAAGAAGAACTGGAACAG Plasmid mutagenesis
SutA S2C R ACATGCTCTGGAAGTACAGG Plasmid mutagenesis
SutA S32C F GCAGTGACGGCGACGAGG Plasmid mutagenesis
SutA S32C R AGTCCGCTTCGCCGTCGT Plasmid mutagenesis
SutA S98C F GCAAGTACGGCAGCCGCC Plasmid mutagenesis
SutA S98C R AGTCCGGCTTCTTCGGCG Plasmid mutagenesis
SutA 6amber F gaaTAggaacaggacgagctggacg Plasmid mutagenesis
SutA 6amber R ttcttcgctcatGCTCTGGAAGTAC Plasmid mutagenesis
SutA 11amber F GtaGGACGGCGCTGACGAG Plasmid mutagenesis
SutA 11amber R TCGTCCTGTTCCAGTTCTTCTTCgctc Plasmid mutagenesis
SutA 22amber F GCGAAGAGTAGGCCGCGGCCGACGACGGC Plasmid mutagenesis
SutA 22amber R CGTCGTCCTCGTCAGCGCCGTCC Plasmid mutagenesis
SutA 54amber F GAAGAGGAATAGCCCTCGGTCGAAGCCAAG Plasmid mutagenesis
SutA 54amber R CACCACGGCGGCTTTCGCCTTCTTG Plasmid mutagenesis
SutA 61amber F gTagaaagagcgtgacgccctcg Plasmid mutagenesis
SutA 61amber R ttggcttcgaccgagggcagt Plasmid mutagenesis
SutA 74amber F GGAGGAATAGCTTTCCCGCGGTGGAAAGG Plasmid mutagenesis
SutA 74amber R ATCGCCTTGGCGAGGGCGTCAC Plasmid mutagenesis
SutA 84amber F TAGGAACCCAACGTGGTGGCCGA Plasmid mutagenesis
SutA 84amber R CTCCTGCACCTTTCCACCGCG Plasmid mutagenesis
SutA 89amber F gTAggccgatccgccgaag Plasmid mutagenesis
SutA 89amber R acgttgggttcgatctcctgcacc Plasmid mutagenesis
SutA 100amber F TAGGGCAGCCGCCCCATCTGAAAG Plasmid mutagenesis
SutA 100amber R CTTGCTGTCCGGCTTCTTCG Plasmid mutagenesis
RpoS gF CCATCATCATCATCATCACGAGAACCTGTACTTCCAGGGCATGGCACTCAAAAAAGAAGG Gibson cloning into plasmid
RpoS gR GAGGCCCCAAGGGGTTATGCTAGTCACTGGAACAGCGCGTCAC Gibson cloning into plasmid
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RpoS pF GTGACGCGCTGTTCCAGTGACTAGCATAACCCCTTGGGGCCTC Gibson cloning into plasmid
RpoS pR CCTTCTTTTTTGAGTGCCATGCCCTGGAAGTACAGGTTCTCGTGATGATGATGATGATGG Gibson cloning into plasmid
DksA gF gagaacctgtacttccagagcATGTCCACCAAAGCAAAACA Gibson cloning into plasmid
DksA gR TCCAAGCTCAGCTAATTAAGCTTTCAGGAGCCGAGTTGCTTCT Gibson cloning into plasmid
DksA pF AGAAGCAACTCGGCTCCTGAAAGCTTAATTAGCTGAGCTTGGA Gibson cloning into plasmid
DksA pR TGTTTTGCTTTGGTGGACATgctctggaagtacaggttctc Gibson cloning into plasmid
RpoD gF CCATCATCATCATCATCACGAGAACCTGTACTTCCAGGGCATGTCCGGAAAAGCGCAACA Gibson cloning into plasmid
RpoD gR GAGGCCCCAAGGGGTTATGCTAGTCACTCGTCGAGGAAGGAGC Gibson cloning into plasmid
RpoD pF GCTCCTTCCTCGACGAGTGACTAGCATAACCCCTTGGGGCCTC Gibson cloning into plasmid
RpoD pR TGTTGCGCTTTTCCGGACATGCCCTGGAAGTACAGGTTCTCGTGATGATGATGATGATGG Gibson cloning into plasmid
RpoD 171-214 F GGTCCGGATCCGGAAGAA Plasmid mutagenesis
RpoD 171-214 R GGGATCGATATAGCCGCTGA Plasmid mutagenesis
RpoB B1_us F GAACCTGTACTTCCAGAGCATGTTGCTGGCCATCCAGCTGGATT Gibson cloning into plasmid
RpoB B1_us R TCCAGCTGGATGGCCAGCAACATGCTCTGGAAGTACAGGTTCT Gibson cloning into plasmid
RpoB B1_mid F TCCCAGCTGCACCGTTCCGGTGGTATCGACCACCTGGGCAAC Gibson cloning into plasmid
RpoB B1_mid R GTTGCCCAGGTGGTCGATACCACCGGAACGGTGCAGCTGGGA Gibson cloning into plasmid
RpoB B1_ds F TTCGAGCCAGCTGTCGCAGTGAAAGCTTAATTAGCTGAGCT Gibson cloning into plasmid
RpoB B1_ds R AGCTCAGCTAATTAAGCTTTCACTGCGACAGCTGGCTCGAA Gibson cloning into plasmid
RpoBfrag pF GACATCGAACTGGAAACCGAATGAAAGCTTAATTAGCTGAGCTTGGA Gibson cloning into plasmid
RpoBfrag pR CGATCCTCTCATAGTTAATTTCTCCT Gibson cloning into plasmid
RpoB355 F GGAGAAATTAACTATGAGAGGATCGCTGAAGATCGACAACACCAGC Gibson cloning into plasmid
RpoB450 F GGAGAAATTAACTATGAGAGGATCGATCGACCACCTGGGCAACCG Gibson cloning into plasmid
RpoB520 F GGAGAAATTAACTATGAGAGGATCGTTCATGGGCCAGAACAACCCG Gibson cloning into plasmid
RpoB626 F GGAGAAATTAACTATGAGAGGATCGACCCTCAACGAGAAGGGTCAAC Gibson cloning into plasmid
RpoBfrag R CAGCTAATTAAGCTTTCATTCGGTTTCCAGTTCGATGTCG Gibson cloning into plasmid
temp_plasmid F CCGCGCAAGGCACAGTCGAAAGACTGGGCCTTTCGTTTTGCTTAATTAGCTGAGCTTGG Gibson cloning into plasmid
temp_plasmid R GCTTCGTGTCGAGCCCTTCGCCACGCCCCTCTTTAATACG Gibson cloning into plasmid
rrn_temp F CGAAGGGCTCGACACGAAGCTTGAAGGTCGGGCGCAAGC Gibson cloning into plasmid
rrn_temp R TTCGACTGTGCCTTGGCGCGGATTCGACTTGTTAAAGAGCA Gibson cloning into plasmid
bcn_tempF CGAAGGGCTCGACACGAAGCGGCGGTCATTTGCCTAACATG Gibson cloning into plasmid
bcn_temp R TTCGACTGTGCCTTGCGCGGTGAGCGATAGCCGGCCCTCT Gibson cloning into plasmid
pepB_temp F CGAAGGGCTCGACACGAAGCGCCAGCGAGCTATCAGCA Gibson cloning into plasmid
pepB_temp R CCAGTCTTTCGACTGTGCCTTGCGCGGCGTTCCTTGTGAGGCGATG Gibson cloning into plasmid
pepB_cy5 F GAAAATAACGCTTGACGGAATTCAGGAATTACGCCAGGAC Template production
pepB_cy3 R AGAGCAGTTGGTCAAGGCTATTGCCCGAAATGTCGC Template production
generic_temp F CGAAGGGCTCGACACGAAGC Template production
rrn_temp_short R CTTGTTAAAGAGCAGTTGGTC Template production
bcn_temp_shortR GTGACTATCGGTTGCCAGC Template production
bcn_forPE_R AGAGCAGTTGGTCAAGGCTATCGGTTGCCAGCCGCT Template production
bubble_T AGGCTTTCGTCTCAACCGAGGCGCGCGTAAGAACAGCAACCTCTCTTTCCGTCAAGCGTTATTTTCGAAAATTTTCTTTT Template production
bubble_NT AAAAGAAAATTTTCGAAAATAACGCTTGACGGAAAGAGAGGTTGCTGTAGAATGCGCGCGGACGGTTGAGACGAAAGCCT Template production
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Cy5 primer ext. Cy5_GAAAATAACGCTTGACGGAA Primer extension
Cy3 primer ext. Cy3_AGAGCAGTTGGTCAAGGC Primer extension
rrn RTforRACE CGAATTCACGAGTGTTAC 5' RACE
rrn RACE_PCR1 F CGAAGGGCTCGACACGAAGCAAAAAAAAAAAAAAAAAA 5' RACE
rrn RACE_PCR1 R TTCGACTGTGCCTTGCGCGGTTGCGCTGCTGATAATCTTG 5' RACE
rrn RACE_PCR2 F CGTATTAAAGAGGGGCGTGGCGAAGGGCTCGACACGAAGC 5' RACE
rrn RACE_PCR2 R CCAAGCTCAGCTAATTAAGCAAAACGAAAGGCCCAGTCTTTCGACTGTGCCTTGCGCGG 5' RACE
RACE plasmid F CCGCGCAAGGCACAGTCGAAAGACTGGGCCTTTCGTTTTGCTTAATTAGCTGAGCTTGG 5' RACE
RACE plasmid R GCTTCGTGTCGAGCCCTTCGCCACGCCCCTCTTTAATACG 5' RACE
oprI qPCR F AGCAGCCACTCCAAAGAAAC qPCR
oprI qPCR R CAGAGCTTCGTCAGCCTTG qPCR
rrn qPCR F ACGAAAGCCTTGACCAACTG qPCR
rrn qPCR R TTGCGCTGCTGATAATCTTG qPCR
bcn qPCR F ACTCGCCACACTTCAGGAAC qPCR
bcn qPCR R AGGTCGTTGGACACCTTGAC qPCR
pepB qPCR F TGCAGAAGCTGGAAGACATC qPCR
pepB qPCR R CTTTCTGCAGGGTCTGCTTC qPCR
Ec_rrn qPCR F TGCTCTTTAACAATTTATCAGACAATC qPCR
Ec_rrn qPCR R CGTGTTCACTCTTGAGACTTGG qPCR
Ec_hcaT qPCR F CTGATGCTGGTGATGATTGG qPCR
Ec_hcaT qPCR R AGTCGCACTTTGCCGTAATC qPCR
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